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ABSTRACT 
Study Investigating Motor Improvement in Cerebral Palsy Patients 
Following Sensory Stimulation 
Background: Cerebral palsy is the commonest cause of physical disability in 
children, with no cure till now. Extensive sensory input to the motor cortices and to 
the motor descending pathways raises the potential of using sensory stimulation of 
the extremities to produce neuroplasticity to improve motor function in cerebral palsy 
patients.  
Objectives: To investigate the effect and usefulness of local palmar vibration therapy 
in improving motor hand function of cerebral palsy children. 
Methods: A single blinded, randomized controlled trial (Registry number 
CTRI/2013/05/003700) was designed to investigate the effect of local vibration 
therapy, a sensory input, on the change in motor hand function in cerebral palsy 
children. Thirty eight cerebral palsy children were screened and 23 were recruited as 
per the inclusion and exclusion criteria, randomised and allocated to treatment and 
control groups. Twenty children completed the study. The control group received 
standard conventional therapy. The intervention group, in addition, received bilateral 
localized 50 Hz palmar vibration therapy daily for 5 min, 5 days per week, for 4 
weeks.  
Results and Discussion: Interim analysis revealed no statistically significant 
difference in the change in hand function or activities of daily living between the 
groups. However, intra-group analysis revealed significant improvement of hand 
dexterity of both dominant and non-dominant hands in the intervention group but only 
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of the dominant hand in the control group, which is suggestive of a beneficial effect 
of vibration therapy in the intervention group. Further, the bilateral improvement in 
hand function in the intervention group, reveals that the protocol used in the study for 
the application of vibration therapy, has no effects of inter-hemispheric cortical 
inhibition on the non-dominant cortex. The findings of the interim analysis defend 
the appropriateness of studying the role of sensory stimulation as a mode of therapy, 
to enhance hand dexterity in Cerebral palsy children. 
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INTRODUCTION: 
Children are the future of the nation. A healthy child will be a healthy adult who is the 
pillar of the human race. Keeping the children healthy is a responsibility of the health 
care system as well as the society by large. Children’s health has been compromised 
due to various reasons all over the world especially in the developing countries like 
India. The reasons that compromise health of child are multifactorial. The socio-
economic-political reasons are poverty, illiteracy, ignorance, abuse, gender 
discriminations and many more. Some of the health related issues that causes child 
mortality are constantly being addressed and the mortality rates are gradually going 
down with the uses of vaccines, improved health care facilities, health education, 
improving nutritional status. Proper antenatal care and taking care of pregnancy 
related issues are also important in addressing child health, since a healthy mother 
gives birth to a healthy baby. The leading causes of mortality among children, mostly 
in the developing countries are Acute Respiratory Tract Infection (ARI) like 
Pneumonia, Diarrhoeal diseases, Measles, Malaria, Malnutrition. Apart from these 
there are disease that can cause increase in childhood morbidity (1). Physical disability 
due to various causes is one of them. 
Physical disability in the children is a major cause of childhood morbidity that goes 
beyond childhood to adult life. Physically disabled children will increase the medical 
expenditure, parental and family discomfort and burden to the society by large. One of 
the major cause of physical disability in children is Cerebral palsy. Cerebral Palsy is 
the commonest physical disability in children with a prevalence of about 3.6/ 1000 live 
birth (2). The prevalence of CP in the developing countries tends to be in a similar 
range. The male to female ratio is around 1.4:1 (2). Cerebral palsy is a disease of the 
developing brain where along with other several disabilities, one of the major disability 
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is motor dysfunction. It is the motor disability that makes these patients crippled and 
dependent on others. Depending upon severity, even performing work for just daily 
living sometimes becomes impossible for them. The cause of this disease is 
multifactorial. Some of the causes are preventable to some extent and some are not. 
There are several modes of management which are currently available but none of 
them offers a cure. Management of cerebral palsy includes management of motor 
dysfunction along with other disabilities like spasticity, speech disorder, dystonia etc. 
Improvement of motor dysfunction requires multi-speciality approach. But no one 
therapy alone is sufficient to manage cerebral palsy. Cerebral palsy is the static 
encephalopathy produced by injury to the developing brain in the perinatal period. 
Clinically it is mainly a disease of posture and movement, although there are other co-
morbidities. CP is topographically classified-into Hemiplegia, Diplegia, Triplegia and 
Quadriplegia (2). To improve the functional ability of these patients, motor 
improvement is crucial. Hence treatment of CP is aimed at improving motor functions 
through a multidisciplinary approach involving physiotherapy, occupational therapy, 
pharmacotherapy and surgery. The normal development of motor functions seen in the 
normal growing child is restricted in the CP child. A contributing factor for this is the 
reduced sensory feedback the child gets, as the interactions of the CP child with the 
surrounding environment is limited. 
Vibration is a form of sensory stimulus which has been investigated as a modality of 
therapy in many conditions like CP, Stroke and Parkinsonism (3–7). Whole Body 
Vibration has been reported to produce motor improvement in CP patients, and local 
site specific vibration has been found to reduce spasticity in CP children (8,9). The 
exact mechanism by which the beneficial effect of vibration is produced is still not 
elucidated.  
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Extensive to and fro connections exist between the sensory and motor areas of the 
brain cortex. The motor cortex receives input from the adjacent sensory cortices, 
namely the primary sensory cortex and the sensory association areas of the parietal 
lobe. Further, 40% of the Corticospinal tract fibres (Motor descending pathways) 
originate from the somatosensory cortices, and only the rest arise from motor cortices 
(10,11). The presence of the extensive sensory input to the motor cortices and to the 
motor descending pathways raises the potential of using sensory stimulation of the 
extremities to produce neuroplasticity and to improve motor function. Would regular 
application of painless sensory stimuli to the palms of cerebral palsy patients enhance 
the excitability of the motor cortex and produce reorganization of the sensory and 
motor cortices through the phenomenon of neural plasticity, leading to improved motor 
functions in these patients? Published literature reports studies, where localized 
electrical stimulation increased excitability and reorganization of the motor cortex. 
This suggests that localized site-specific vibration of the hands alone may contribute 
to improved motor function of the hands. The present study addressed this question by 
randomizing cerebral palsy patients of age group 6 - 15 years, into control and 
intervention groups. Standard treatment was given to both groups. In addition, 
vibratory stimuli was applied to both palms of the intervention group. The extent of 
improvement of hand function, as assessed by the Box and Block Test in the two 
groups, has been compared. Further, the change in Activities of daily Living, measured 
using Modified Barthel Index, has been compared. The present study is an interim 
analysis of an ongoing randomized controlled trial, approved by the Institutional 
review Board and registered under Clinical trial registry of India. 
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REVIEW OF LITERATURE 
CEREBRAL PALSY: 
Cerebral palsy (CP) is a term used to describe a group of disorders causing physical 
disability in children and adults. It is a heterogeneous group of clinical syndromes 
which is characterized by dysfunction of motor and posture due to insult to the 
developing brain due to various causes. Cerebral palsy is a non-progressive disorder 
of the nervous system and a static encephalopathy, but the clinical features change as 
the brain matures over time. The clinical presentation is dynamic. CP may present 
during infancy with delayed motor development milestones (12). Impaired motor 
function in CP is thought to be due to decreased motor recruitment in the central 
nervous system and also due to changes in the muscle morphology as a secondary 
effect of motor dysfunction (13). 
HISTORY OF CEREBRAL PALSY: 
The term cerebral palsy has been known to the world since very ancient time. It was 
used to describe the people with physical disability mainly due to motor dysfunctions. 
Cerebral palsy has also been found in literature in the history Cerebral palsy has been 
documented in historical records of civilisations. These sources, however, are based 
on suspicion since clinical documentations were lacking at that time.  An engraving 
of a picture of a person with a crutch on a tombstone dating back to 15th to 14th century 
BC is considered by historians to depict a person afflicted with cerebral palsy. 
Probably the oldest case of suspected cerebral palsy comes from the evidences on the 
mummy of an Egyptian pharaoh called Siptah who ruled around 1196 to 1190 BC 
(14). He died at an early age with features of a disease consistent with cerebral palsy. 
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The history of medical literature also refers to a “cerebral palsy like disease” as a 
known entity. The Greek medical literature uses the term palsy to denote paralysis. 
They have described paralysis or weakness of the limbs in their literature. Roman 
history also suggests diseases similar to cerebral palsy. One of the Roman emperor 
called Claudius probably had a disease which from its description had resemblance 
with Cerebral palsy (14). 
The history of modern medicine finds the first documentary representation of CP in 
the work of Hippocrates in "Corpus Hippocraticum" (14). The proper definition and 
description of cerebral palsy was given by William John Little at the beginning of 
ninetieth century. He was the first person to engage himself in the study of cerebral 
palsy to a great extent. He came out with many new concepts of cerebral palsy. He for 
the first time, threw some light on the aetiology or risk factors of the disease. He 
suggested that prematurity and problems during delivery could be responsible for the 
disease. Later, spastic diplegic CP was named after him as Little’s disease (14). 
Subsequently, William Gowers found a relationship between problem in delivery and 
the occurrence of paralysis in newborns and mentioned the disease as “birth palsy”. 
Based on his observation he also made a classification of “birth palsy” as peripheral 
and cerebral. 
After William John Little, the person who reviewed the disease maximally was 
William Osler (1849–1919). He classified the problem and linked the causation of the 
disease with problems at the time of delivery. However, he along with many 
investigators made mistakes like erroneously linking the disease with some non-
related diseases like poliomyelitis (14). 
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Renowned psychiatrist Sigmund Freud (1856-1939) who practised initially as a 
neurologist worked further on the aetiology of the problem and found it as a problem 
occurring before birth or at the time of delivery or after the baby is born. He described 
the clinical features of the disease and linked it to the sites of brain damage.  
During the twentieth century many people worked on cerebral palsy and many new 
approaches to therapy, including surgery, came to focus. One of the important 
classification system of cerebral palsy called Gross Motor Function Classification 
System (GMFCS) was developed in 1997 by Robert Palisano et al (15). 
The significant developments in the understanding of CP that followed since then, are 
all due to the contributions of these three personalities in the field of cerebral palsy: 
William Osler, Sigmund Freud and Robert Palisano. 
EPIDEMIOLOGY OF CP: 
Cerebral Palsy (CP) is the commonest physical disability in children with a prevalence 
of about 2-2.5/ 1000 live births (16–18). The prevalence of CP in the developing 
countries tends to be in a similar range (18,19). In India, the figure is around 2- 2.8/ 
1000 live births (19). A recent study conducted by the Centre for Disease Control and 
Prevention (CDC) in 2008 has shown few other important epidemiological facts about 
cerebral palsy such as that the disease is more common in males than females. The 
study also found that spastic type CP is more common and accounts for 77.4% of the 
cases. Epilepsy (41%) and Autistic Spectrum Disorders (ASD) (6.9%) were found to 
be important common co-morbidities  as per the study (17). A group of different 
studies which were conducted at different time points, in different places like Europe, 
Sweden, United Kingdom and Ireland all made the same observation that incidence of 
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cerebral palsy is much higher in babies with low birth weight than in babies whose 
birth weight is normal (20,21). Moreover, the incidence of severe neuromotor 
disability of around 10% was seen in babies born at or below 25 weeks of gestation 
(22). One review of several studies showed that 12% of babies born at or below 26 
weeks of gestation and 8% of babies born at or below the birth weight of 800 gm 
developed cerebral palsy (23). It has also been found that the risk of cerebral palsy is 
higher in babies who are born with a birth weight at or below the 10th percentile of 
normal than babies whose birth weight is within 25th – 75th percentile of normal. The 
risk of developing cerebral palsy is lowest in babies who are born with a birth weight 
of more than one standard deviation above the mean (24,25). However, recent studies 
show that there is a decreasing trend in the risk of developing cerebral palsy, even in 
premature and low birth weight babies, probably due to advanced and better perinatal 
care in recent times (26,27).  
AETIOLOGY OF CEREBRAL PALSY: 
The causation of cerebral palsy is multifactorial (28). Majority of them occur due to 
problems during either foetal development or the neonatal period (29). However the 
cause of the condition still remains unknown in most cases of established CP (30). The 
injury to the developing brain may be prenatal, natal or postnatal. The causes can be 
due to congenital, genetic, inflammatory, infectious, anoxic, traumatic and metabolic 
disorders. Prenatal maternal chorioamnionitis, infection, drug or alcohol abuse, 
maternal epilepsy, hyperthyroidism, severe toxaemia, third trimester bleeding, 
prematurity and Cystic Periventricular Leukomalacia are some of the risk factors for 
developing Cerebral palsy (12,18). Prematurity alone was found to be present in 78% 
of the cases followed by intra uterine growth retardation and intra uterine infection in 
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34% and 28% of the cases respectively. Antepartum haemorrhage and placental 
pathology were found in 27% and 21% of cases. Multiple pregnancy as a causation of 
cerebral palsy was found to be present in 20% of cases (28). There has also been 
reports of association of maternal alcohol intake during pregnancy with development 
of cerebral palsy in the baby (31–33). Maternal heavy smoking and vaginal infection 
were also found to be associated with cerebral palsy (34). The following pathological 
conditions described below are established risk factors for cerebral palsy. 
Hypoxic Ischemic Encephalopathy (HIE): 
Frequently, cerebral palsy is described as being associated with perinatal asphyxia. 
However, hypoxia related injury alone does not contribute much in the causation of 
CP (35–38). HIE is a group of disorders where due to hypoxic insult to the brain at an 
early age, neuronal damage occurs leading to abnormal neurological functions 
manifested as seizures, unconsciousness, depressed body tone and reflexes and even 
cardio-respiratory malfunctioning which may be fatal. There are some markers of 
outcome of HIE that have a positive correlation with the development of CP (39). The 
disorders that are linked to the development of CP are seizures, hypotonia, multiple 
organ dysfunctions, severe persistent low APGAR score and coma (40).  
Congenital problems: 
Congenital abnormalities including structural brain defects, chromosomal aberrations, 
genetic abnormalities are also potential risk factors for developing cerebral palsy (41–
46). Congenital deformities are present more commonly in cerebral palsy patients; 
53% in quadriplegic CP and 35% in Non-quadriplegic CP (47). Both central nervous 
system and Non- central nervous system deformities are found in patients with 
14 
 
cerebral palsy (43). Babies born with breech presentation are also at risk  of developing 
cerebral palsy (48,49).  
Prematurity: 
Prematurity is the single most important cause of cerebral palsy. Prematurity 
associated pathological conditions are mainly responsible for this. Premature babies 
who usually suffer from Periventricular leukomalacia (50), Bronchopulmonary 
dysplasia, intracranial haemorrhage (51) are more prone to develop CP. 
Cerebrovascular accidents: 
Cerebrovascular accidents in the form of cerebral thromboembolism or intracranial 
haemorrhage or stroke may lead to cerebral palsy in the babies. Intracranial 
haemorrhage though less frequent, may occur in patients with coagulopathy and they 
are more prone to develop the CP and about 28% of the cases have associated 
neurodevelopmental abnormalities (52). Thalamic haemorrhage is common in infants 
with some predisposing factors like cerebral venous thrombosis due to infections and 
congenital heart diseases. The thalamic haemorrhage may lead to neurodevelopmental 
disorders after infancy (53).  
Multiple births: 
The risk of developing CP increase in case of multiple pregnancy as in the case of 
twins and other higher order pregnancies (54). The reasons for this can be attributed 
to low birth weight and congenital anomalies of the foetus. Cord around the neck and 
dysfunctions of vascularity are also more common in multiple births which in turn 
15 
 
contributes to the development of CP (55). Even death of a foetus in a twin increases 
the risk of development of CP in the other due to thromboembolic insult (54). 
Maternal infections: 
Various infections of the mother during antenatal period are risk factors for the baby 
in developing cerebral palsy. Many complications to babies may occur like infection 
in the foetus or in the new born including septicaemia and meningitis. These diseases 
can cause neurodevelopmental disorders. Both bacterial and viral infections are 
responsible for the risk. Common infections that occurs in mothers are Syphilis, 
Toxoplasmosis, Varicella infection, Rubella, Cytomegalovirus (CMV) and Herpes 
infection (TROCH infections). The microbes causing all these diseases can cross the 
placental barrier and cause infection or damage to the foetus. This is a risk factor for 
developing cerebral palsy.  Other bacterial agents can also cause serious infections to 
the mother. Mother may give history of having developed chorioamnionitis. This is 
again a risk factor for developing CP (56,57). The association can also be attributed to 
other complications occurring in the neonate as a consequence of maternal infection 
and these can also increase the risk for developing CP. The complications in the 
newborn due to maternal chorioamnionitis are perinatal hypoxia, neonatal meningitis, 
convulsions. High fever in the mother at the time of delivery due to any infections also 
increase the risk of developing cerebral palsy (57,58). 
Obstetric complications: 
Different maternal obstetrics complications like Premature rupture of membrane, 
antepartum haemorrhage, placental insufficiency, hypoxia, traumatic delivery, 
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Meconium stained liquor causing meconium aspiration syndrome,  may contribute to 
the risk of the baby  developing CP (59).  
Perinatal infections in baby: 
Neonatal septicaemia and meningitis, TORCH infections affect the nervous system. 
As a complication of these diseases, neurological dysfunctions may occur which may 
lead to development of CP. Even infections by non-bacterial pathogens like viruses 
and fungus, can cause cerebral palsy (60,61).  
Trauma: 
Trauma to the brain due to any reason may damage the developing brain and may 
predispose to development of cerebral palsy (59). 
Genetic disorders: 
Thrombophilia, as evidenced by the presence of  factor V Leiden or Antiphospholipid 
antibody in mother or in the baby, has got a role in the aetiology of CP (62). Cytokine 
polymorphism is also a risk factor (59). 
Drug induced: 
Cerebral palsy may occur in babies whose mother had taken different drugs which can 
cross placenta and affect the foetus with its teratogenic effect (59).  
Bilirubin encephalopathy: 
Neonates for the first seven days of life have underdeveloped blood brain barrier. So 
substances which normally cannot pass through the blood brain barrier, will cross the 
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neonatal blood brain barrier to eventually reach brain tissue. Bilirubin in unconjugated 
form, is one such substance which can cross the Blood Brain Barrier and destroy the 
neurons and supporting cells in the brain of neonates, whenever its serum level 
becomes very high due to any cause. Due to many reasons serum level of bilirubin 
may go up in neonates causing pathological jaundice. One of the main causes of 
pathological jaundice is Rh incompatibility, where the sensitized Rh negative mother’s 
anti D antibodies destroys the baby’s red blood cells causing severe haemolytic 
jaundice. This is an example of unconjugated hyperbilirubinemia and this high level 
of unconjugated bilirubin can cross the Blood Brain Barrier and get deposited in brain 
structures like basal ganglia and nuclei of the brain stem. The unconjugated bilirubin 
destroys the neuron and the neuroglial cells in these regions causing bilirubin 
encephalopathy. One of the major and severe consequence of this is kernicterus. The 
survivor develops severe neurodevelopmental dysfunctions. The babies may develop 
choreo-athetoid cerebral palsy later in life (1,2).  
Other metabolic disorders: 
Prenatal maternal metabolic problems like iodine deficiency, different hormonal 
disorders like hypothyroidism of the mother can be risk factors for developing cerebral 
palsy (2,63). 
Hypoglycaemia and vitamin K deficiency in the baby in the natal and post natal period 
can also be metabolic risk factors, other than kernicterus, for developing CP (64). 
Maternal prenatal medical/ surgical problems: 
Seizure disorders in the mother, vascular insufficiency in the form of thromboembolic 
disorders causing hypoxic effects, psychosomatic disorder in mother, anti-
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phospholipid syndrome, babies born  through in-vitro fertilization, maternal traumatic 
injuries may lead to development of cerebral palsy in the baby (59).  
PATHOLOGY OF CEREBRAL PALSY: 
The pathological finding in cerebral palsy patients are confined mostly to the central 
nervous system. The muscle morphology also becomes defective according to some 
studies (13). The peripheral nervous system is spared in CP. The observed pathological 
changes  in cerebral palsy due to different aetiologies (59) are: 
i) Hypoxic injury 
ii) Diffuse neuronal damage 
iii) White matter injury 
iv) Periventricular leukomalacia 
v) Neuronal necrosis 
vi) Cerebral haemorrage in different areas 
vii) Intraventricular haemorrhage 
viii) Subependymal parenchymal destructions 
ix) Infarction of cerebral cortex 
x) Gliosis 
xi) Status marmoratus 
xii) Brain structural malformation 
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PATHOPHYSIOLOGY OF CEREBRAL PALSY: 
Pathogenesis of cerebral palsy is injury to brain due to various reasons, by various 
mechanisms at cellular level. The neuronal injury and subsequent different 
pathological changes are due to hypoxia, ischaemia, infection or inflammation. The 
destruction of cells is caused by inflammatory mediators, free radicals, microglia 
mediated free radical destructions and calcium mediated tissue injury (50). Cytokine 
and other proinflammatory mediators cause destruction of tissues (65). The reactive 
oxygen species and nitrogen species mediated cellular damage, the neurotransmitter 
like glutamate mediated excitotoxicity are also other reasons for neuronal cell death 
(65). The tissue destruction can cause demyelination and destruction of 
premyelinating oligodendrocytes (50,65).  
CLASSIFICATION OF CEREBRAL PALSY: 
Cerebral palsy is classified based on different types of neuromuscular abnormalities. 
They are spastic, dyskinetic (with chorea, athetosis and dystonia), ataxic (simple and 
diplegic), hypotonic and mixed. Spastic CP is the commonest type seen and accounts 
for 70%-75% of all cases. Topographical classification of spastic CP patients is into 
Hemiplegia, Diplegia, Triplegia and Quadriplegia patients (12).  
Spastic Cerebral Palsy:  
The patient presents with hypertonia and signs and symptoms of upper motor neuron 
type of lesions. The increased tone prevents the patients from carrying out motor 
functions like impaired gross and fine motor movements. Motor skills are less 
developed in these patients. They get tired easily and suffer from fatigability. The 
spasticity itself causes some exaggerated motor signs which actually are signs of upper 
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motor neuron lesion and prevents the patient from carrying out normal motor 
functions. Exaggerated deep tendon reflexes, planter or patellar clonus, excessive tone 
of both flexor and extensor group of muscles are seen during stressful voluntary action. 
The spasticity is further aggravated in stress. The normal movement and posture are 
greatly affected. The complex movement of any particular action cannot be executed 
properly. Continuous increased tone in the patient, except during sleep may make the 
concerned extremity rigid and deformed (2,12,13,18).  
Spastic Monoplegic CP: This type is relatively less common than the other 
topographically classified varieties of cerebral palsy. The spastic monoplegia involves 
single limb with impaired voluntary motor performance and increased tone and also 
signs of upper motor neuron lesions.  
Spastic diplegic CP: This is one of the common types of cerebral palsy. While many 
of the studies  report spastic diplegia as the commonest (30-40%), some studies report 
an occurrence of  22%   and as the second commonest type of CP, after spastic 
quadriplegia (2,12). Spastic diplegia occurs due to various aetiologies including 
periventricular leukomalacia, cystic changes, infarction, and prematurity, metabolic or 
endocrinal abnormalities and infections (2). The clinical features include spasticity of 
both lower limbs with symmetrical or asymmetrical involvement. The upper limbs 
may or may not be affected. In some cases of spastic diplegia the upper limbs are 
affected to a greater extent than others. The associated abnormality like sensory loss 
is common, whereas seizure is seen less and intellectual activity is less impaired. The 
voluntary motor activity of both lower limbs are greatly affected. Sitting, walking and 
other activities using lower limbs, like dressing, are difficult for them. They suffer 
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from spasticity related complications, and morbidity like contracture and deformities 
which further limit their activities (2,12,66). 
Spastic triplegic CP: This is again a relatively less common type of cerebral palsy. The 
motor functions of three of the limbs are impaired. 
Spastic quadriplegic CP: This involves motor functions of all the four limbs. Patients 
are more severely affected than the other types. The associated brain pathologies 
detected through neuroimaging are disorders like prematurity, low birth weight (67), 
brain dysgenesis, infarction, periventricular leukomalacia, cystic encephalomalacia 
and many structural brain defects like schizencephaly. Genetic, metabolic and 
endocrinal abnormality can give rise to Quadriplegic CP. Ischemic events or infection 
can also be responsible for development of this type of CP (2). The children suffer 
from various comorbidities like seizure disorders, musculoskeletal deformities, speech 
abnormalities, visual disturbances and low intelligence. They are prone to develop 
recurrent respiratory tract infection or pneumonia due to recurrent aspiration of food 
content into the respiratory tract owing to pseudo bulbar palsy (2,12). Spasticity, 
contracture, deformity and severe motor disability are common (68,69).  
Spastic hemiplegic CP: One half of the body is typically involved in this type of 
cerebral palsy. Cerebrovascular accidents like infarction due to thrombosis and 
embolism may give rise to spastic hemiplegia (70–73). Hypercoagulability, infection, 
placental abnormality, congenital heart disease and vascular malformations are some 
of the contributing factors for thromboembolic incidences (74,75). The patients 
usually present after infancy with one sided motor weakness and hemiplegic posture. 
There is deformity of the affected side of the limbs due to contracture of the muscles. 
They have a hemiplegic gait which becomes more prominent during walking. There 
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is more tone of the flexor group of muscle (12). There is also associated comorbidity 
due to recurrent seizures and visual impairment (75). Facial nerve palsy is also 
common in this group of patients (12). Sensory system may also be affected in some 
cases (76). The patients may have cognitive disturbances as well (77,78).  
Dyskinetic Cerebral palsy:  
This type of CP patients predominantly has involuntary movement disorders. The 
affected babies might have had perinatal hypoxic insult. Kernicterus due to neonatal 
unconjugated hyperbilirubinaemia and consequent bilirubin encephalopathy also 
causes dyskinetic CP. Genetic or metabolic abnormalities can also be attributed to its 
development (2). The babies present with lethargy and decreased movement. But 
involuntary movements are common in the form of chorea or athetosis. This type may 
further be classified based on the predominant movement disorder associated with 
them, like dystonic or choreoathetotic. The pathological brain lesions and resultant 
extrapyramidal effects are due to involvement of the basal ganglia or thalamus.  
Choreoathetoid type of dyskinetic CP is classified based on the predominant 
movement disorder associated with it, of either chorea or athetosis. Patients with 
choreiform symptoms have rapid, jerky, involuntary movement of part of the body. 
Patients sometimes also presents with ballismus, a more severe type of chorea (79).  
Dystonic type of dyskinetic CP patients present with dystonia or abnormal tone, along 
with pyramidal tract lesions. They usually have limb involvements as well. Dystonic 
CP can present with a normal tone or with hypotonia but in some form the tone may 
also be increased. There is rapid or slow, involuntary, repetitive, twisting limb 
movements which may get intensified with emotional stress. They also have 
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abnormality of speech and cognition. The dystonia also varies with change of body 
position, emotional status or sleep (12). 
Ataxic Cerebral palsy: 
Ataxic cerebral palsy is associated with dysfunction of cerebellum or sensory nervous 
system (79). The coordination and gait are abnormal along with other abnormal motor 
functions. Delayed developmental milestones are present. They also have speech and 
cognitive impairment. The problem may be due to perinatal insult or genetic 
abnormalities. Ataxic CP can be of two types depending on presentation and the 
associated comorbidities like simple ataxic CP and ataxia with diplegic CP. 
Hypotonic Cerebral Palsy: 
Hypotonic CP is also sometimes named as Atonic CP which is characterized by 
profound decrease in tone of the muscles. The patients are severely disabled and 
cannot even stand up by themselves. The developmental milestones are markedly 
delayed. The dependency level is very high. They also have poor cognitive ability. 
Structural brain malformation, agenesis, microcephaly are some of the aetiological 
factors (2).  
CLINICAL FEATURES OF CEREBRAL PALSY: 
Clinical features of cerebral palsy are varied and depend on clinical staging and 
classification and severity of the disease at presentation. The afflicted babies present 
with delayed developmental milestones. Though the disease is non-progressive, its 
clinical presentation changes over time. Primarily, cerebral palsy is a disease of motor 
system and posture. But it can affect the functions of central nervous system globally. 
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Motor impairment may be accompanied by sensory and autonomic impairment but the 
peripheral nervous system is usually spared (80–82). The clinical presentation can also 
be due to involvement of other systems, as complications affecting those are common.  
The symptoms actually vary with regard to certain factors, like the age at which the 
patient presents, the classification of the disease, severity and dependency.  
i) History of risk factors 
ii) Inability to perform motor functions for the age 
iii) Increased tone, spasticity 
iv) Dystonia 
v) Involuntary movement 
vi) Not gaining weight 
vii) Delay in speech 
viii) Hearing problem 
ix) Problem in vision 
x) Excessive tightness of limb muscle 
xi) Convulsions – recurrent 
xii) Poor academic performance 
The signs are again dependent on the age at presentation and type of CP and severity 
of the disease. The cerebral palsy is usually diagnosed after infancy and mostly after 
third year of life. Since the developmental milestones for a normal developing child 
varies with age, the clinical signs are also variable. Delayed developmental milestone 
at any age is one important sign of the disease.  
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CO-MORBIDITIES OF CEREBRAL PALSY: 
Though cerebral palsy is mainly a disease of motor function and posture, there are 
several other comorbidities which coexists in several patients (75 %) (12). The 
following comorbidities have been identified (83). 
i) Cognitive impairment: 50 % of all patients suffering from Cerebral palsy 
also suffer from some form of cognitive and intellectual impairment. 
Quadriplegics are more prone to develop cognitive disability than other. 
They also have some form of speech and language disability and also other 
learning disorders (83). 
ii) Seizure disorders: 25 % of patients have epilepsy or seizure disorders. This 
is more common in quadriplegic, hemiplegic and atonic CP. They also 
have some associated learning disability (83). 
iii) Behavioural problems: They also have some behavioural disorders in about 
25 % of cases (83). 
iv) Sleep disturbances: 20 % of the CP patients have sleep disturbances (83). 
v) Speech disorders: This is found in about 25 % of cases and that can be 
attributed to pre-existing poor cognition and deafness. The poor oral and 
pharyngeal muscle activity and incoordination are responsible for the 
disorder (83,84). 
vi) Visual disturbances or blindness: Blindness as a comorbidity in CP patients 
are found in about 10 % of cases. Visual cortical lesion, refractive errors, 
retinal diseases and squint are found in patients (85,86).  
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vii) Deafness: 4 % of the patients are deaf or have other forms of hearing loss. 
Sensorineural hearing loss is common in patients with kernicterus (87). 
There may be lesion in the auditory cortex due to hypoxic insult (88). 
viii) Autism: Many of the patients of CP (6.9 %) have autism spectrum 
disorders. It is more common in atonic CP than in other varieties (89). 
ix) Urinary diseases: Bladder control problems are present in 25 % of cases of 
CP. Urinary urgency, hesitancy, poor capacity, stress incontinence, 
detrusor instability and neurogenic bladder are not uncommon (90–93). 
x) Drooling: Due to weakness of the oropharyngeal muscle there is poor 
control of mouth closure and 20 % of the patients present with drooling. 
xi) Feeding difficulties: Poor motor control of oropharyngeal muscle due to 
severe motor disabilities, 7 % of the patients have some form of feeding 
difficulties and may require even gavage feeding for survival (83). 
xii) Pulmonary diseases: The patients suffer from pulmonary diseases due to 
recurrent aspiration of food and resultant aspiration pneumonitis. This is 
due to incoordination of muscles of palate and pharynx. The thoracic cage 
and spinal deformity is also responsible for recurrent pulmonary diseases. 
Pulmonary diseases are one of the leading cause of death in cerebral palsy 
patients (94). 
xiii) Musculoskeletal disorders: 75 % of the patients have feeling of pain due to 
a battery of reasons. 30 % of cases have hip displacement. 30 % of CP 
children cannot even walk at all (95). There is also presence of several 
deformities of limbs, thoracic cage and spine (96).  
xiv) Osteopenia: The cerebral palsy patients suffer from osteopenia due to lack 
of movement, muscular weakness and nutritional deficiency of 
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micronutrients (97,98). The patients have low bone mineral density and are 
prone to experience fractures for the same reason (99). 
xv) Malnutrition: Feeding difficulty, gastro intestinal diseases like gastro 
oesophageal reflux disorders, recurrent aspirations, constipation makes the 
patients prone to develop malnutrition and consequent stunting of growth 
and growth failure (100–103).  
xvi) Dental abnormalities: Recurrent reflux of stomach acid content makes the 
patient prone to develop dental diseases (104).  
FUNCTIONAL CLASSIFICATION OF CEREBRAL PALSY: 
Cerebral palsy is classified by a number of classification system based on dependency 
and severity. Gross Motor Function Classification System (GMFCS) is one of the most 
popular scale to classify CP (105). It classifies CP into five levels in ascending order 
of severity. Another classification system based on how the cerebral palsy children 
use their hand function to initiate motor activity is referred to as the Manual Ability 
Classification System (106).  
DIAGNOSIS OF CEREBRAL PALSY:  
CP is mainly diagnosed clinically with supportive evidence from radiological studies 
and many other different investigations, but investigations can neither exclude nor 
confirm the diagnosis (16).  
A careful history and clinical examination is pivotal in diagnosis. Abnormal 
neurological signs, impaired motor development, delayed developmental milestones, 
abnormalities in tone and posture, signs of comorbidities will suggest a provisional 
diagnosis along with presence of positive history and risk factors. Investigations like 
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screening for blood coagulation disorders and screening for metabolic disorders are 
important. Other investigations which can exclude other diseases or support the 
diagnosis of cerebral palsy will help in reaching a definite diagnosis. 
Magnetic resonance imaging (MRI): Brain lesions can be picked up by magnetic 
resonance imaging (107,108). MRI is also more informative than CT scan. 
Electroencephalography (EEG): Patients with epilepsy or seizure disorders are 
investigated using EEG (73). 
Cranial Ultrasonography: This is also used to diagnose neonatal stroke along with 
other modalities of investigations (73). 
Lumber puncture: Patients with resistant convulsions are investigated by lumber 
puncture to rule out other neurological disorders.  
Testing for genetic and metabolic diseases: Screening for genetic and metabolic 
diseases are also done (87). 
Children with CP are also investigated for visual and auditory abnormalities. Brain 
stem Evoked Potential is measured. Testing using ophthalmoscope is also carried out 
to find comorbidities.  
 
MANAGEMENT OF CEREBRAL PALSY:  
There is currently no cure for CP and treatment is mainly supportive to improve quality 
of life by improving functional ability either by improving motor function or by the 
use of assistive devices or techniques (109). Management of cerebral palsy is 
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multidisciplinary (110). The participation of departments of Paediatrics, Neonatology, 
developmental paediatrics, paediatric sub specialities, Neurology, Orthopaedics, 
Surgery, Physical Medicine and Rehabilitation, Ophthalmology, otorhinolaryngology, 
psychiatry is necessary for holistic approach in managing the disease. The 
management plan and approach also differ among patients since the presentation and 
the complaints and the disabilities are different in different patients of different type 
and classification of illness. The plan of management is prioritized for speech and 
language development, communications skill development, educational improvement, 
improvement of activities of daily living, attaining a close to normal appearance, 
improvement of growth and nutrition and overall betterment of motor functions.  
Medical management: Medical management includes drug therapy mostly to decrease 
spasticity. Abnormally increased tone is treated by muscle relaxants like Diazepam, 
Dantrolene and Baclofen (111). Other drugs like Trihexyphenidyl, Scopalamine, 
Glycopyrrolate are used as anticholinergic drugs for different problems like drooling 
in CP (112–114). Botulinum toxin is used to reduce spasticity (87,115,116).  
Surgical management: To relieve spasticity the commonest surgical procedure done is 
selective dorsal rhizotomy (117). To improve deformities tendon release surgeries are 
also done called muscle-tendon surgeries (118).  
Orthopaedic therapy: Plaster of Paris casting of the affected limb is done to relieve 
spasticity in case of deformity. But definite evidence of improvement is yet to be 
confirmed (119).  
Physiotherapy: Physiotherapy is one of the mainstays of management for 
rehabilitation. Muscle strengthening exercises, stretching, active exercise for both 
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upper and lower limb, trunk control exercises and gait training are part of 
physiotherapy. There are also some other techniques that are used to improve motor 
performance like Bimanual training, constraint induced movement therapy, Goal 
directed training, context focused therapy, self-care management and fitness training 
(13). 
Occupational therapy: The patients are rehabilitated with the help of occupation 
therapy training. These include improving balance in different postures like sitting, 
standing and kneeling. Balance is improved by different techniques. Gross motor skills 
are improved by active exercise and these include rolling, sitting, standing and transfer 
activities. The hand function is very important for rehabilitation for better quality of 
life and for activities of daily living and many more. Hand functions can be improved 
by several methods to improve reach, facilitate grasp, pinch, hand manipulation of 
objects and hand writing. Activities of daily living (ADL) training is one of the most 
important part of therapy since this helps in elevating the quality of life of patients and 
in helping them to have a near normal appearance. The ADL training involves all the 
daily necessary activities of life like maintaining personal hygiene, bathing, eating, 
dressing, toilet training and also training to improve motor function to facilitate 
mobility, chair or bed transfer, walking, climbing stairs and even training on wheel 
chair for those who are unable to sustain mobility in spite of all available measures 
(13). 
Behavioural and cognitive therapy: Since about 50% or more of the CP children have 
cognitive and intellectual impairment and many of them have behavioural problems, 
cognitive therapy is employed for them. Behavioural therapy is also useful in 
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correcting many behavioural problems in cerebral palsy children including 
management of drooling along with pharmacological therapy (120).  
Play: different types of age appropriate play is also part of occupational therapy (121). 
Speech therapy is employed for patients with dysarthria and motor dysfunction 
involving oropharyngeal muscles. 
Psychiatric therapy: Patients with psychiatric problems are assessed by a psychiatrist 
and different problems like temper tantrums, depression, and agitation are treated by 
both pharmacological therapy as well as non-pharmacological therapy like 
psychotherapy and behavioural therapy. 
Deep brain stimulation therapy can be used for dystonic cerebral palsy, but the 
supportive evidences are not strong (122). 
Some other therapies are also tried on cerebral palsy patients without a promising 
result. Neuromuscular electrical stimulation, threshold electrical stimulation, 
functional electrical stimulation (FES), hyperbaric oxygen therapy, sensory 
integration therapy, massage therapy, hydrotherapy, neurodevelopmental therapy are 
some of the examples which are not recommended due to either lack of definitive 
evidences or because of other available better therapies (123).  
Supportive therapy: Supportive therapy in the form of psychological therapy, 
counselling, and social support are important in relieving psychological stress, social 
stigma of both the patients and the parents and the family at large. Counselling is done 
to explain to the parents about the disease, causation, management, outcome and 
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prognosis. It also relieves parent’s anxiety and improves the quality of care of the child 
(121). 
Vibration therapy: There are evidences that show that vibration therapy can improve 
motor functions in cerebral palsy patients. But there are also reports that suggest that 
the results of vibration therapy are not promising. The vibration therapy can be given 
either as whole body vibration or localized vibration (3–5,124,125).  
PROGNOSIS OF CEREBRAL PALSY:  
The prognosis of cerebral palsy depends on the stage of the disease and the associated 
comorbidities. The milder form of the disease has better prognosis than the severe 
form of the disease. Associated comorbidities like seizure disorders, status epilepticus 
and other related complications worsen the prognosis.  
ROLE OF IMPROVEMENT OF HAND FUNCTION IN THE MANAGEMENT 
OF CEREBRAL PALSY:  
Cerebral palsy is managed by multidisciplinary approach (110). None of the single 
therapy alone is sufficient to manage these patients. Aim of management is to give a 
near normal status to patient as far as possible. That is why different approaches are 
sought to improve different parameters of the disease condition. Improving motor 
function is one of the most important aims in management since this is essential for 
becoming self-efficient to carry out work for earning a living. To improve quality of 
life and activities of daily living, ensuring a good hand function is one of the essential 
elements that need to be addressed. Studies show that about 83 % of the patients of 
CP have motor involvement of the hands. 36 % of patients have clinical contracture 
and 69 % of patients of CP have poor clinical hand functions (126). The impaired hand 
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function is definitely an important factor for poor quality of life and morbidity. 
Activities of daily living need a good hand function for obvious reasons. Improving 
hand motor function is thus important in CP. 
Improving hand function and improvement of ADL 
The Activities of Daily Living (ADL) is a tool to assess the motor performance of the 
patients in day to day activities. It includes ADL training and assessment. The 
parameters assessed for ADL are maintenance of personal hygiene like brushing, 
cleaning face, washing hands, personal grooming, shaving or combing hair, bathing 
and managing toilet activities. Feeding, dressing and many more activities are also 
included (127). An individual needs a reasonably good motor functioning of the body, 
especially good motor function of hands to perform these daily activities The gross 
manual dexterity is one of the independent predictors of the motor hand function 
activity of cerebral palsy patients (128).  
PHYSIOLOGY OF HAND FUNCTION IN RELATION WITH CP: 
Motor system of hand:  
Motor system of hand includes both upper motor neuron (UMN) and lower motor 
neuron (LMN) system that control the hand function.  
The lower motor neuron (LMN) system comprises of the alpha motor neurons present 
in the anterior horn of spinal segments C5 to T1, whose axons compose the motor 
branches of the brachial plexus and form the motor innervations of muscles of upper 
extremity. The main motor nerves are median nerve, ulnar nerve and radial nerve. 
Axillary nerve and musculocutaneous nerve also contribute to the motor supply of 
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upper extremity. The nerves supply all the skeletal muscles of upper extremity. The 
hand is also supplied by these same nerves which supplies all the small muscles of 
hand which are important in executing coarse and fine movements of hand and fingers. 
Lower motor neuron system, is intact and unaffected in cerebral palsy patients (2).  
Upper motor neuron system of hand starts from the cerebral cortex itself. The motor 
cortices are responsible for the motor functions and control of the body. The primary 
motor cortex is situated in the pre-central gyrus (Brodmann’s area 4) in the frontal 
lobe. The cells are arranged there in a columnar organization. There are six layers of 
cells in the cerebral cortex. The external and internal granule cell layers receive inputs 
from thalamus and also from other cortical regions. From the external and internal 
Pyramidal cell layer efferent tracts originate (10). The motor cortex is somatotopically 
organized. There is a large area of representation of hand in the motor homunculus. 
The supplementary motor area projects to primary motor cortex. The premotor cortex 
projects to the primary motor cortex, brainstem reticular formation and spinal cord 
(11).  
Lateral corticospinal tract is formed by the axons of UMNs, whose cell bodies are in 
the cerebral cortex. 31 % of these fibres originate from neurons in the primary motor 
cortex (from Brodmann’s area 4). The cell bodies of these neurons form the pyramidal 
cells of cortical layer V which includes Betz cells (giant pyramidal cells). 29 % of 
fibres originate from neurons of premotor & supplementary motor areas (from 
Brodmann’s area 6) and 40 % of fibres arise from the neurons of primary 
somatosensory areas (Brodmanns’s area 3, 1, 2) and somatosensory association areas 
of parietal lobe (from Brodmann’s areas 5 and 7). Each area of the cortex is 
somatotopically organized. So the UMN axons which will ultimately be responsible 
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for motor activity of hand will come from the motor hand area. Hand area has got 
larger area of representation than other areas in both somatosensory and motor 
cortices. The axons of the UMN then descend down as corona radiata. The corona 
radiata converge and pass down through the posterior limb of the internal capsule and 
descend down to the brain stem. There it passes through cerebral peduncles of the 
Midbrain and then through Ventral Pons. Then it descends further and forms the 
Pyramids of the Medulla. At the level of the lower part of medulla, 85 % of the fibres 
cross over to the opposite side (at the level of Pyramidal decussation). The crossed 
fibres then descend down further into the spinal cord to form the lateral corticospinal 
tract, which is important for voluntary control of fine, skilled and precise movements 
of hand and also foot and digits. The remaining 15 % of the fibres are uncrossed. They 
descend as anterior corticospinal tract ipsilaterally. These fibres control the axial and 
proximal girdle muscles. They are involved in controlling the posture and stability of 
trunk muscles for smooth distal limb activities (10,11,129).  
The lateral corticospinal tract descends in lateral column of spinal cord and ultimately 
terminates by synapsing with alpha motor neurons of anterior horn of the spinal cord 
which supplies the distal limb muscles. These alpha motor neurons which supply the 
distal limb muscles, form the dorso-lateral group of anterior horn cells (129). The 
lateral corticospinal tract fibres terminate in almost the entire cord, but mostly at 
cervical and lumbosacral enlargements. That is why motor activity of hand mostly 
depends on the integrity of lateral corticospinal tract. The anterior corticospinal tract, 
on the other hand, descends in the anterior column of the spinal cord. Some of the 
fibres of the anterior corticospinal tract cross in spinal cord to terminate on 
contralateral alpha motor neurons which supply contralateral axial and proximal girdle 
muscles (10,11,129). UMN is affected in cerebral palsy (2).  
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Sensory system of hand: 
The sensory system of the hand, which detects sensory inputs such as touch, pain, 
temperature, proprioception and vibration and carries the information about these 
somatic sensations to the cerebral cortex, comprises of a three-order neuron system. 
The receptor that detects these sensations are present in the skin and subcutaneous 
tissues of hands (130). The receptor transmits the information picked up and 
transduced by it, to the first order neurons of the sensory pathway. The information is 
further transmitted to the second order neurons which passes on the information to the 
third order neurons which terminate in the Primary somatosensory cortices. 
Cutaneous receptors: Different types of cutaneous receptors are present in the body 
which carry bodily senses. The sensory receptors are of different types such as the 
mechanoreceptors, nociceptors and thermoreceptors. Each receptor is specialised to 
detect mainly a specific modality of sensation. Free nerve endings which are 
minimally specialized receptors, send impulse through axons of C, Aδ fibres. They are 
slowly adapting receptors and carry pain, temperature and crude touch from skin of 
whole body. Their threshold of activation is high. Mechanoreceptors present over 
palm are Merkel’s disc, Meissner’s corpuscle, Ruffini’s corpuscle and Pacinian 
corpuscle. Each of the receptor differs in their property of activation, position, shape 
and size. Merkel’s discs are encapsulated nerve ending. Impulse from Merkel’s disc 
is carried by the Aβ fibres. They are present in all over skin and carries touch and 
pressure. They are slowly adapting receptor and their activation threshold is low. 
Meissner’s corpuscles are present between the dermal papillae and found in the 
glabrous skin. Signal from them are carried by the axons of Aβ fibres. They are rapidly 
adapting receptors and carry touch, pressure and vibration at a frequency of 20 – 50 
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Hz. Their threshold of activation is also low. The density of Meissner’s corpuscle in 
glabrous skin of hand is high. They have receptive field of 2-3 mm in diameter in the 
finger tips and 10 mm over palm. The Pacinian corpuscles are encapsulated, onion like 
structure present in the subcutaneous tissue. They can be activated by deep pressure 
and vibration at a frequency of 60- 100 Hz. Impulse is carried by the axons of Aβ 
fibres. They are rapidly adapting receptors and activation threshold is low. Ruffini’s 
corpuscles are also situated deep into the skin and activated by stretching of the skin. 
They are slowly adapting receptors and activation threshold is low. Impulse from 
Ruffini’s corpuscle is carried by Aβ fibres (11,129,130). The mechanoreceptors 
converts mechanical energy to electrical energy. The receptive field over superficial 
skin has got many highly sensitive points due to presence of Meissner’s corpuscles 
and Merkels’s disc, whereas Pacinian corpuscles and  Ruffini’s corpuscles have single 
point of maximally sensitive receptor field in the deeper layer (129). Touch, pressure 
and vibration over the mechanoreceptors produce receptor potential which is a 
nonpropagated, depolarizing, graded potential. When the graded potential reach a 
threshold level, it can produce an action potential in the first node of ranvier and the 
impulse is transmitted proximally through the sensory nerve (11).  
Vibration is a sensory stimulus that is produced by the sinusoidal oscillation of any 
object placed over the skin. These oscillations are sensed by a pulse code by the 
cutaneous mechanoreceptors. With each cycle of oscillatory sinusoidal wave, one 
action potential is developed.  Then the sensory nerve action potential transmits the 
vibratory signal. The vibration frequency is signalled by the action potential frequency 
(129). Vibration at 50 Hz which is the intervention used in the present study stimulates 
Meissner’s corpuscles (10,129).  
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Sensory nerves carry information from the sensory receptors. The receptor potential 
which is formed by the action of vibration stimulus is transmitted to the sensory nerve 
and the developed action potential travels through the axons of the peripheral nerves, 
like the median nerve, ulnar nerve, radial nerve and others. The axons of the sensory 
nerves carrying vibration sensation from the receptor, form the first order neurons, 
whose cell bodies are present in the dorsal root ganglion. The central axon of these 
pseudo unipolar neurons enter the spinal cord through the dorsal root and from lamina 
III to VI ascends in the posterior column of spinal cord. These dorsal column fibres 
synapse with neurons of nucleus gracilis and nucleus cuneatus in the medulla. The 
axons arising from nucleus gracilis and nucleus cuneatus form the second order 
neurons, which cross over to the opposite side at the Great sensory decussation of 
medulla and ascend up as the medial lemniscus to synapse with the third order neurons 
in the ventro posterolateral nucleus of the thalamus. The axons of the third order 
neurons then project up to terminate in the primary somatosensory cortex (S1) which 
projects to the secondary somatosensory cortex (S2) and to the sensory association  
cortices. The sensory cortex is also somatotopically organized like the motor cortex 
and hand area has got a greater area of representation in the cortex (10,11,129).  
Relationship between sensory and motor cortices: 
There are extensive to and fro connections between the motor cortices and sensory 
cortices. The primary motor cortex (M1) receives somatosensory afferents. The motor 
cortex receives inputs from the somatosensory cortex. The somatosensory input is 
relayed in such a fashion that it comes from an area which is homologous to the motor 
cortex. Since both the sensory and motor cortex are somatotopically organized, the 
sensory outputs from one area of sensory cortex transmits tactile and proprioceptive 
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information which projects to the same functional area of representation of that region 
in the motor cortex. So the somatosensory area for hand representation sends tactile 
and proprioceptive inputs to the motor hand area which when excited causes 
movements of muscles of hands. The inputs do not come directly to the motor cortex 
from the somatosensory area. It is relayed through thalamic relay nucleus. The ventral 
posterolateral nucleus of thalamus is also somatotopically mapped like the 
somatosensory and motor cortices. So the relay is also organized somatotopically from 
somatosensensory area of hand representation to the area of hand representation in the 
thalamus to the corresponding hand area of primary motor cortex (10).  
Another observation that may show the sensory-motor connection is elicitation of M2 
wave in EMG. If a peripheral muscle is stretched or stimulated, two different waves 
of different latencies are seen in the EMG. A short latency M1 response followed by 
a long-latency M2 response is generated. The M1 wave is the short latency response 
which is produced due to monosynaptic connection of Ia afferents to the spinal motor 
neurons. The M2 response is generated as the sensory signal is transmitted via the 
motor cortex. In patients with Klippel-Feil syndrome the M2 wave is seen bilaterally, 
if one limb is stimulated. The corticospinal neurons in Klippel-Feil syndrome branch 
out abnormally and they supply the spinal motor neurons bilaterally. So the sensory 
motor connection at the motor cortical level can be evidenced by the generation of M2 
wave (129,131). 
There is contribution of neurons of somatosensory areas to the descending motor 
pathways also. 40 % of fibres arise from the neurons of primary somatosensory areas 
(Brodmanns’s area 3, 1, 2) and somatosensory association areas of parietal lobe (from 
Brodmann’s areas 5 and 7). Each area of the cortex is somatotopically organized. 
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These neurons project to the dorsal horn of the spinal cord and also to medullary dorsal 
column nuclei. Their function is to send a positive sensory feedback to the motor 
cortex for a smooth movement. They respond to a change of limb position, rate of 
movement and magnitude of muscular force of contractions during movement (10). 
Assessment of hand motor function:  
Motor functions of hand can be evaluated clinically by assessing the bulk, tone and 
power of the hand muscles. However, this would be a subjective method.  More 
objective and reproducible methods of evaluation of hand function are by using 
different scales like Box and Block test for manual dexterity (132), Fine finger 
dexterity test (Purdue Peg-board Test) (128), Manual Ability Classification System 
(MACS) (106,133), Toronto Rehabilitation Institute–Hand Function Test (TRI-HFT), 
Grasp and release test, Sollerman hand function test, Jebsen hand function test, 
Minnesota manual dexterity test, Action Research Arm Test (ARAT), GRASSP, 
AuSpinal (134), Jamar dynamometer, and handheld dynamometer (135). 
Box and block test for manual dexterity: 
The Box and Block test for manual dexterity is a simple, easy to assess, inexpensive 
test to assess manual dexterity or the hand functions in patients. Box and Block test 
results positively correlate with the MACS results in cerebral palsy patients (136). It 
is useful in assessing hand function in other conditions also, like Brachial plexus injury 
(137). This test has been validated in children in the age group of 6 – 19 years 
(128,132). There are also reports of studies which have used the Box and Block test 
to accurately assess hand function in CP children (128,136,138) of 6-19 years. 
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Approaches to improve motor functionality:  
There are many approaches that can be adopted to improve motor functions in patients 
having motor impairment. The motor impairment range from flaccid paralysis of 
muscles, to hypertonia and spastic paralysis of muscles, to contractures of limbs. The 
strategies are pharmacological therapy like administration of drugs that decrease tone 
of skeletal muscle and thus decrease hypertonia and spasticity (111). This in turn will 
facilitate the movement of muscles with ease. Drugs like centrally acting muscle 
relaxants are used for this purpose. Botulinum toxin is another option for the same 
purpose (87,115,116). There are non-pharmacological therapies to take care of 
spasticity as well. Exercise, different types of physiotherapy, different modes of 
occupational therapy can help in relieving hypertonia. Another option is surgical 
therapy which actually takes care of the limbs which have been severely deformed due 
to contractures developing secondary to prolonged neglected hypertonia. Tendon 
release surgeries  relieve  the contracture and improve the range of mobility (118). 
Selective dorsal rhizotomy is also done for treatment of spasticity (117). Serial casting 
can also relieve spasticity and contracture.  
Apart from management of spasticity, improving power of muscle is crucial for motor 
performance. Techniques like Bobath neurodevelopmental approach assist the child 
with cerebral palsy to get rid of abnormal postural tone and also improve control of 
posture (13). Motor performance can be improved by active exercises. Active exercise 
improves muscle power.  
Physiologically, strategies to improve motor performance may be classified as those 
measures that strengthen the upper motor neuron system, those that tackle the lower 
motor neuron system and techniques that target the skeletal muscles themselves. 
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Upper motor pathways can be enhanced by increasing the recruitment of motor 
cortical neurons for a given task. This can be achieved by strengthening the synaptic 
connections that impinge on the motor cortical neurons and increasing the excitability 
of the pool of motor cortical neurons.  
Cerebral palsy is a disease of the upper motor neurons. There is damage to the 
developing brain due to various aetiologies. The injury causes damage or death of the 
neurons in brain. Thus the motor cortical neurons are affected in CP. The resultant 
weakness of the limbs, reduces limb movements which further decreases the 
excitability of the surviving motor cortical neurons of the CP patient due to the 
prolonged disuse of the limb. The absence of  the normal volley of proprioceptive 
inputs from the paralysed limb to the cortical neurons would contribute to this (139). 
Thus the purpose of improving brain function is to strengthen the viable as well as the 
damaged neurons of the motor cortices so that their functional output can be improved. 
So increasing motor cortical excitability is one way to restore the existing upper motor 
neuronal activities. Motor cortical excitability can be increased by different ways. One 
way of achieving this is by increasing the activity of the concerned muscles or 
increasing the movement of the involved limbs, which by a feedback mechanism can 
increase the excitability of those motor cortical areas which have the upper motor 
neuron control of the concerned muscles or limbs. The  phenomenon by which the 
functional properties of the motor cortical neurons are altered is called Motor cortical 
plasticity (140). Motor cortical excitability can also be increased by sensory 
stimulation of the involved limb or part of the body. This phenomenon is called Cross 
system plasticity (140).  
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NEUROPLASTICITY 
Neuronal plasticity is the ability of neurons to change their property of response to 
stimulation. The mature neurons of the adult human brain are not capable of cell 
division or regeneration, with the exception of the hippocampal neurons. However, 
the human brain is capable of changing the structural and functional organization of 
the existing neurons and this is possible at any age. Neuroplasticity occurs naturally 
to cope with different changes in external or internal environmental of the body. It 
occurs to achieve various purposes. It can help different brain activities like cognition. 
The property of neuroplasticity can be exploited therapeutically to treat several 
conditions like traumatic brain injury, neurological brain impairment, insomnia and 
various psychological disorders. It probably forms the basis of Cognitive Behavioural 
Therapy (141). Previously it was difficult to study neuroplasticity owing to lack of 
proper tools to study. Hence animal models were used to study neuroplasticity 
initially. But with the advent of recent advances in technology like Transcranial 
Magnetic Stimulation (TMS), studying of neuroplasticity has been made easier. TMS 
is a non-invasive, painless technique that can be used to study the mechanism of 
neuroplasticity. Proof of principle studies show that application of TMS can even 
induce or modulate cortical plasticity in humans. With the help of TMS and TMS-
EEG co-registration neuroplasticity is studied (142). In TMS-EEG co-registration the 
TMS pulse is given on the head and at the same time EEG is recorded. This it can 
provide information about the cortical excitability directly and instantaneously. It also 
can give ideas about the dynamics of brain functions (142). 
Though both adult brain and the developing brain of child are capable of modulating 
brain wiring, it is more prominent in an infant’s brain. The mature adult brain can 
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undergo dynamic plastic changes in in response to different sensory inputs originating 
from the environment or from within the body. In addition, mature adult neurons can 
also modulate in response to efferent demands and also in response to behavioural 
changes (142). The neural networks of human brain executes specific functions but 
also may be modulated. Though one specific area of cortex is designated for the 
functions of a particular part of the body, it can modulate itself to take charge of the 
control of other parts of the body by strengthening or weakening pre-existing synaptic 
connections of those cortical neurons. Babies learn new skills and information by the 
property of plasticity of neurons. In this process, the neurons can form new synapses, 
may branch out and form new synapses to strengthen connections. Neuronal 
connections may also be removed by natural selection due to paucity of stimulation or 
other reasons in infants. In fact, pruning of synaptic connections occur markedly after 
birth till the adult brain develops (143). The strength of the neural connections will 
deteriorate in the absence of sensory inputs. The classic paper by Hubel and Wiesel in 
1965 experimentally showed for the first time that sensory inputs are necessary for 
formation of synaptic pathways of vision in new born kittens (144). This is essentially 
an example of neuronal plasticity. 
Though naturally occurring reinforcement or deterioration is common in infants and 
children, adults also exhibit considerable neuronal plasticity. This becomes evident in 
circumstances where adults are learning new things or un-learning existing patterns of 
behaviour or connections. Learning new skills, memorising new facts, recovering 
functions of limb after damage are all examples of neural plasticity. Plasticity can 
occur in neocortex in both sensory and motor areas. Memory is the prototype area of 
learning where plasticity has been described maximally through different experiments 
(129). The physiology of plasticity has been described through many mechanisms. The 
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types of plasticity is based on the different types of mechanisms. Due to short term or 
long term reorganizations in the connections and behaviour of neurons, circuits, 
synapses and overall network, adaptability to new sensory stimulation occurs. It is also 
possible to memorize new information, recover lost limb functions,  acquire  new skills 
and development through the phenomenon of neuronal plasticity (142).  
The neural plasticity is of different types based on different mechanism of actions 
(102,129,142,145). A classification of plasticity has been portrayed in Figure 1. 
 
Figure 1: Classification and mechanism of neuroplasticity. (LTP: Long term 
potentiation; LTD: Long term depression) 
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Neuroplasticity has been broadly classified into functional and structural. Functional 
neuroplasticity can be synaptic, non-synaptic or both. Synaptic connection strength is 
reinforced and amplified or there could be synaptic weakening through 
neuroplasticity. Reinforcement occurs in an existing neuronal structural network. The 
structure of neuron, synapse and network connection remain same. The synaptic 
change occurs by changing the pattern and strength of electrical transmission. These 
changes occur by different mechanisms.  
Based on time taken for changes to develop, functional neuroplasticity can be 
classified into short term potentiation and long term potentiation. It can also be 
categorised based on the type of change produced at the synapse by the functional 
plasticity, into long term potentiation and long term depression.  
Cellular mechanisms of Synaptic plasticity can be divided into two. It can be through 
electrical and chemical changes producing changes in synaptic transmission leading 
to synaptic plasticity. Another is morphological or structural changes of synaptic 
connections involving increased protein synthesis and where new dendrites are formed 
or synaptic contacts are removed (129). 
The onset of developing long term plasticity is very rapid but the effect of enhanced 
synaptic strength stays for long time. Unlike short term potentiation this occurs at post 
synaptic level and develops after a presynaptic neuron is stimulated repeatedly. Short 
term potentiation occurs at presynaptic level. The cellular events that occurs at the 
level of presynaptic neuron, can increase or decrease the strength of synaptic 
transmission. The synapse is a junction of a presynaptic neuron and a post synaptic 
neuron. Changes that occur in the pre-synaptic neuron and thereby causes changes in 
the strength of synaptic transmission is said to occur at the level of presynaptic neuron. 
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It reflects presynaptic changes. Changes in Intracellular Ca2+ is the main factor for 
development of all the different types of synaptic plasticity and there will not be any 
synaptic plasticity in absence of Ca2+ (129,145,146). Short term potentiation typically 
lasts for 10 seconds to several minutes. Repetitive stimulation of neuron can increase 
or decrease the strength of synaptic transmission for a short period of time. They are 
of different types based on the period of their action.  
 Facilitation is a type of functional synaptic plasticity where the effect is seen 
for 10-100 milliseconds.  
 Augmentation lasts for several seconds.  
 Potentiation lasts for 10 seconds to several minutes. 
Another variant of short term functional plasticity is depression which occurs if the 
frequency of stimulation is increased. Habituation, on the other hand occurs in 
response to a low frequency stimulation. The mechanism of action of short term 
synaptic plasticity is due to increase in intracellular Ca2+ concentration due to prior 
repetitive tetanic stimulation. The action potential that follows tetanic stimulation 
causes considerable increase in intracellular Ca2+ in the presynaptic neuron. The 
increase in strength of synaptic transmission is due to enhanced release of neuroactive 
peptide from the presynaptic neuron through exocytosis secondary to high level of 
intracellular Ca2+.  Habituation, on the other hand occurs due to decreased quantal 
release of neurotransmitter in response to a repeatedly applied benign or harmless 
stimulus (145).  
Hebbian-like Long term potentiation (LTP) increases the neuronal synaptic strength 
of transmission. Here the changes occur in the post synaptic neuron. There is increased 
post synaptic potential developing in response to a stimulus applied subsequent to a 
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train of impulses that pass through the synaptic connections. The onset of developing 
this type of plasticity is very rapid but the effect of enhanced synaptic strength stays 
for long time. Unlike short term potentiation this occurs at post synaptic level and 
develops after a presynaptic neuron is stimulated repeatedly. Mechanism of 
development of LTP is either NMDA receptor mediated (NMDA receptor dependent) 
or NMDA receptor independent. NMDA receptor, AMPA receptor and Metabotropic 
Glutamate receptors are expressed in the post synaptic membrane. Complex 
interactions among these receptors at the cellular and molecular level brings about 
LTP (129,142,146).  
Sometimes there is also weakening of synaptic strength, a phenomenon known as long 
term depression (LTD). The mechanism of action and types of long term depression 
can be mediated by different receptors. It can be NMDA receptor‐dependent LTD 
(NMDA‐LTD), Metabotropic glutamate receptor‐dependent LTD (mGluR‐LTD) and 
LTD through cannabinoid type 1 (CB1) receptors (CB1-LTD). The main intracellular 
event which is responsible for long term synaptic plasticity is changes in concentration 
of intracellular Ca2+. A very sharp rise of intracellular Ca2+ for very short period of 
time initiates long term potentiation, while moderate increase in intracellular Ca2+ 
level which sustains for a long period of time initiates long term depression. Changes 
in Intracellular Ca2+ is the main factor for development of all the different types of 
synaptic plasticity.  
Another form of functional synaptic plasticity is metaplasticity which is a type of non-
Hebbian plasticity. It is a form of homeostatic plasticity. Here there is overall gross 
modulation of synaptic transmission and excitability of neuron. The changes are based 
on experience. The mechanism of action of metaplasticity is not yet known properly. 
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Involvement of neuroglial cells and release of tumour necrosis factor-alpha have been 
postulated. The global nature of this form of plasticity is called ‘plasticity of synaptic 
plasticity’ (147). 
Functional plasticity can also be non-synaptic where there is change and modulation 
of conductance of ion channels in the neurons. The transmission of neuronal action 
potential or synaptic potential requires expression of ion channels and their activation. 
One of the important type of channel involved in the transmission of the action 
potential are the voltage gated ion channels. Other ion channels play an important role 
for maintaining the resting membrane potential and hence the excitability of neurons 
(11,129,145). The modulation of these channels can change the membrane potential 
and can modulate the neuronal transmission. Modulation of neuronal transmission can 
change the excitability of the concerned brain area and allow neuroplasticity to occur 
(148). 
GABAergic neurons are inhibitory neurons and exhibit high level of plasticity. They 
are responsible for overall gross changes in the neuronal excitability in brain. The 
plasticity in these neuronal circuit plays a crucial role in somatosensory cortex 
(146,149).  
Neuroplasticity can also occur structurally. Various structural changes like synapse 
number, formation or deletion of neuronal branches and many more are responsible 
for structural neuronal plasticity. Other different changes are changes in anatomical 
connections between neurons, Changes of connections of synapses, structural changes 
in neurons like changes of structures of axons and dendrites, their branching type, 
number and also plasma membrane of neuron. Structural changes will also modulate 
the cortical excitability. Structural changes of plasticity is also time dependent in 
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different parts of the central nervous system. Synaptic structural changes and changes 
of structure of dendritic spine can occur very rapidly, from hours to days. But 
macroscopic structural changes involving axonal projections and also dendritic spine 
take place relatively slowly, from days to weeks (129,142,146). Reinforcement of 
neuronal connection through formation of new synaptic connections, increases the 
excitability of brain. Similarly, removal of one or more synapses from the circuit can 
decrease the strength of neural transmission of impulse. Plasticity also occurs by 
remodelling an existing pathway to a different circuit. Structural plasticity is more 
common in adults where they help in formation of new neural connections. The 
formation of structural plasticity is a complex procedure and involves many factors.  
Neurotransmitters may play an important role in establishing structural plasticity. 
They may act as a neurotropic factor that helps in the genesis of new connections and 
change in structural organization of neurons or they simply can modulate the 
electrochemical activities in the circuit and thereby facilitate neuronal transmission 
(146).  
One of the known processes of structural plasticity is through synaptic rewiring. This 
is more relevant in the formation of long term memory. When there is damage of a 
pre/post- synaptic part of a neuron due to any reason, the synapse formed by that part 
becomes non-functional and eventually deleted from the network. The remaining part 
of the damaged neuron now can make new connection by strengthening of a pre-
existing synaptic connection which had been kept inhibited up till now by the synapse 
of the neuron which was damaged. Damage of that neuron releases the other synapse 
from inhibition or allows strengthening of this previously weakened synapse (143). 
Synaptic rewiring may also be possible by formation or deletion of dendritic spines, 
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sprouting of new branches, rearranging new network in an existing connection, 
reconnecting quiescent neuronal branch, making a new connection, generating new 
dendritic spine and synapse (146).  
Another form of experience dependent plasticity that occurs in human brain is Spike 
time dependent plasticity. This also is a form of hebbian type of learning and is time 
dependent (146,150). This involves different cellular mechanisms. This has a time 
dependent change of excitability of post synaptic neuron to stimulation in the 
presynaptic neuron. Spike time dependent plasticity (STDP) occurs in two forms of 
which one is excitatory and the other is inhibitory. Pre-leading post firing, where the 
presynaptic spikes comes before the post synaptic action potential, causes excitation 
of post synaptic membrane and causes long term potentiation. This is usually NMDA 
receptor mediated LTP. Here the post synaptic membrane receives repeated firing 
form the pre synaptic membrane before the post synaptic membrane fires. If the 
presynaptic impulse spikes comes about 0 -20 milliseconds before the onset of post 
synaptic spike, the resultant post synaptic potential is potentiated (146,151). Another 
form of STDP is related to long term depression. The depression of post synaptic 
potential occurs when the temporal sequence of the stimulus is pre leading post firing. 
Here the post synaptic action potential starts before the repeated presynaptic spikes 
come. If the interval between the two is 0 to 20-50 milliseconds, there is depression of 
resultant post synaptic action potential. This causes long term depression and it is 
either NMDA receptor mediated or cannabinoid receptor mediated LTD (146). The 
classical mechanisms are NMDA receptor mediated LTP and LTD, NMDA receptor 
mediated LTP and cannabinoid receptor (CB1) mediated LTD and metabotropic 
glutamate receptor (mGluR) mediated LTD (146).  
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The effect of neural plasticity in increasing or decreasing excitability of brain in one 
or different areas is possible because of connectivity of brain. The neuronal 
connections of brain is organised in different ways (142,152). The inter relation of this 
organization helps in creating plasticity in brain areas. The brain connectivity is mainly 
based on two principles. Neurons in the brain segregate themselves in an area and 
execute same function together in that area. Here one group of neurons are responsible 
for the control and functions of one area. This principle is called segregation (152). 
Another is called integration, where more than one group of neurons exert a global 
function by organizing themselves with neuronal connections. Their actions are 
coordinated among themselves. Integration is relevant for cognition and behaviour. 
Brain connectivity has also been described in space and time (152). The spatial 
connectivity comprises of axonal interconnection within an area of cortex or between 
the different layers of the cerebral cortex. The axons can also connect two or more 
different cortical areas. When plasticity occurs in the neurons or synapse of these 
connections, it is called cross system plasticity (140).  
Types of brain connectivity can be of anatomical connectivity where physical 
connections of neuronal networks are present and functional connectivity. Functional 
connectivity of brain is time dependent (153). The effective connectivity is liaison 
between the anatomical and functional connectivity. All the two types of connectivity 
of brain are interrelated to each other (142,153). Their relationship and temporal 
causation is not fully understood. Different models describe the relationship 
differently.  Some propose that stimulation can induce rapid structural connectivity 
first, followed by development of functional plasticity following exposure to 
subsequent stimuli. Others argues that it is probably functional plasticity that rapidly 
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occurs first following stimulation, and subsequent stimuli forms the structural 
component of connectivity (142). 
Techniques to study effective connectivity include functional Magnetic Resonance 
Imaging (fMRI), Electroencephalography (EEG), Transcranial magnetic Stimulation 
(TMS) Magneto encephalography (MEG) and Positron emission tomography scan 
(11,142). 
Sensory stimulation in improving motor function: 
Improvement of motor functions can be gained by exploiting the property of neural 
plasticity. One of the known fact about motor cortical plasticity is that repeated 
movement of a part of a body can increase the motor area of representation of that part 
in the motor cortex. Likewise, prolonged dis-use of a limb or part of a limb can cause 
regression of size of the motor cortical area of representation. Similarly area of 
somatosensory representation of a limb moves to the surrounding areas if that limb or 
part of it is removed. Moreover, somatosensory map of adjacent areas can encroach to 
that cortical area which used to be the sensory map of the non-used limb. Interestingly, 
if a part of the somatosensory cortex which represents a particular part of body is 
removed, the somatosensory map of that part gets shifted to the adjacent areas 
(11,129). This is an excellent example where the body naturally exploits the 
phenomenon of cortical plasticity to restore the functions of a damaged cortical area. 
There are extensive to and fro connections between the motor cortices and sensory 
cortices. The primary motor cortex (M1) receives somatosensory afferents. The motor 
cortex receives inputs from the somatosensory cortex. The somatosensory input is 
relayed in such a fashion that it comes from an area which is homologous to the motor 
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cortex. Since both the sensory and motor cortex are somatotopically organized, the 
sensory outputs from one area of sensory cortex transmits tactile and proprioceptive 
information which projects to the same functional area of representation of that region 
in the motor cortex. So the somatosensory area for hand representation sends tactile 
and proprioceptive inputs to the motor hand area which when excited causes 
movements of muscles of hands. The inputs do not come directly to the motor cortex 
from the somatosensory area. It is relayed through thalamic relay nucleus. The ventral 
posterolateral nucleus of thalamus is also somatotopically mapped like the 
somatosensory and motor cortices. So the relay is also organized somatotopically from 
somatosensensory area of hand representation to the area of hand representation in the 
thalamus to the corresponding hand area of primary motor cortex (10). 
So repeated stimulation of somatosensory cortex by afferent impulses generated by 
the application of vibration stimulus to a peripheral part of the body, can increase 
excitability of the representative area of the somatosensory cortex.  This 
somatosensory area in turn will send recurring impulses to stimulate the corresponding 
area in the motor cortex, triggering plasticity and increased connectivity in that part of 
the motor cortex.  
Mechanisms through which sensory stimulation causes motor plasticity: 
There are evidences that shows that sensory stimulations causing modulation of motor 
cortical excitability. Animal studies have shown that stimulation of somatosensory 
cortex by electrical stimulation of trigeminal nerve activated the primary motor cortex 
(154). Studies have shown that stimulation of ulnar nerve by electrical stimulus can 
increase the excitability of the cortical motor neurons (155). Electrical stimulation of 
the hand via whole-hand-mesh-glove has been reported to induce increased motor 
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cortical excitability (156). Other studies demonstrated the beneficial effect of a single 
session of peripheral sensory nerve stimulation by surface electrode applied over wrist 
which stimulated the Median nerve, and improved the motor function of hand in 
subacute stroke patients (157). Changes in sensory input may alter the excitability of 
motor cortex which is referred to as cross-system plasticity. A study has shown that 
short period of electrical stimulation of pharyngeal muscles  produced increased 
cortical area of motor representation in healthy human volunteers that sustained for a 
long period of time (140).  
Types of sensory stimulation: Different sensory stimulations can be applied to bring 
about cross system plasticity and to increase excitability of motor cortex. Use of 
electrical stimulation of nerve, whole hand electrical stimulation, functional electrical 
stimulation, proprioceptive stimulation in the form of vibration stimuli, vibrotactile 
stimulation and auditory stimulation have been described to  produce increased motor 
cortical excitability or improvement of motor function (3,156,158).  
Usefulness of vibration therapy: Vibration is a form of sensory stimulation which has 
been used to treat patients with various forms of motor impairment. Vibration therapy 
has been reported to produce improvement in patients with Stroke, Parkinsonism and 
Cerebral Palsy (3–7). Whole body vibration (WBV) therapy has been found to be 
useful in increasing hip bone mineral density (BMD) and increase muscle strength and 
no side effect was observed after 6 months of therapy (159). WBV in randomized 
controlled trial showed demonstrable improvement in muscle strength and balance in 
diplegic cerebral palsy patients (4). Another randomized controlled trial among 
cerebral palsy children using WBV found improvement in mobility (5). Vibrotactile 
stimulation can relieve spasticity by decreasing muscle tone and has been shown to 
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improve mobility in cerebral palsy patients (3). Adult patients with stroke also showed 
preliminary improvement in muscle strength following whole body vibration therapy. 
It was also found to be safe in them (6). WBV along with exercise has been found to 
be useful in  raising the blood level of cortisol and IGF1 in geriatric population (160). 
Vibration alone is more effective in increasing skin blood flow and microcirculation 
in normal healthy individual than vibration with exercise or exercise alone (161). 
Vibration can also be useful in improving cognition and attention span in young 
individuals (162). However, there are also studies those failed to show any significant 
improvement in motor functions following vibration stimulation in stroke patients 
(163,164).  
Local Vibration: Vibration therapy can be applied as whole body vibration or 
regional vibration. Site specific vibration therapy in diseased and healthy individuals 
has shown improvement of function of motor system. Regional vibration therapy over 
the trunk region in patients of spastic cerebral palsy has shown improvement of posture 
and gait of these children. But regional trunk vibration did not show any improvement 
in muscle power or reduction of spasticity. However, no side effect has been reported 
(124). Focal muscle vibration in the form of repetitive muscle vibration (rMV) 
therapy, over the upper limb of chronic stroke patients, improved the motor functions 
(8). TMS studies have shown that focal hand vibration can increase motor cortical 
excitability in healthy human subjects (165) while others have shown that focal 
vibration of lower limbs decreased the spasticity in cerebral palsy patients (9). Another 
TMS based study has shown that application of vibration stimulation over the 
immobilized arm can prevent the inter-hemispheric inhibition of the contralateral 
cortex by the ipsilateral normal cortex. The hemispheric balance is also maintained in 
case of limb immobilization if vibration is applied on the affected limb. These findings 
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also corroborate with the principle of constraint induced movement therapy for 
rehabilitation of adult stroke patients (139). But low amplitude vibration on one limb 
is capable of modulating excitability of both motor cortices. In patients with 
immobilized one limb, EMG output from the muscle is decreased following 
transcranial magnetic stimulation of contralateral motor cortex. This is probably 
mediated by transcallosal inter-hemispheric inhibition mechanism (166). Children 
with meningomyelocoele with damaged neuron, have movement restriction. Muscle 
vibration can improve the muscle strength and mobility (167).  
Dosage of vibration:  
Vibration for improving motor functions has been used in previous studies. The most 
commonly used effective vibration frequency is 12-100 Hz (3,9,125). Studies have 
administered vibration therapy for various durations ranging from single episode of 
application daily for 3 days, once weekly for 12 weeks, to 5 days a week for 6 months 
(3,125).  
Mechanism of Vibration induced neuroplasticity: 
The mechanism by which whole body vibration produces improvement of the motor 
function of CP children has not been clearly elucidated. WBV stimulates most of the 
structures of the body, including skin, bone, muscles and even endocrine glands 
(3,159–161). The exact mechanism by which WBV increases muscle power has not 
been clearly elucidated. Investigators have also attributed the effects to stimulation of 
muscle spindles and spinal motor neurons (168). Moreover it can stimulate the 
proprioceptive pathways and can stimulate the somatosensory cortex (139).  
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Comparison between Whole Body vibration and local vibration: 
In the present study, we studied the effect of local area vibration applied bilaterally to 
the palms of CP children aged 6-15 years. The vibration is not aimed at any specific 
muscle but is intended to stimulate the tactile sensory receptors of the palm, and 
thereby provide sensory feedback to the sensory and motor cortices of the brain. The 
procedure is painless and without any deleterious effects (124). The equipment for 
producing localized vibration therapy is manufactured at a lower cost than the 
equipment required for whole body vibration and hence is available for purchase at a 
lower price. Many such products are currently available in the Indian market for 
purchase at low prices. The most commonly used effective vibration frequency is 12-
100 Hz (3,159–161). In our study we used a frequency of 50 Hz which is known to 
stimulate Meissner’s corpuscles (10,129). 
The rationale of the present study: 
In the present study, local site-specific vibration was given to the palms of both hands 
of CP children in the intervention group. The rationale for choosing vibration is that it 
can be easily quantified in terms of frequency and duration of application of stimulus, 
when compared to other forms of mechanical, tactile, thermal and noxious stimuli. We 
postulate that site specific vibration given to the palms would stimulate the ascending 
sensory pathways (dorsal column pathways) carrying vibration sense to the primary 
somatosensory cortex (S1) which project to the secondary somatosensory cortex and 
to the sensory association areas (10,11,129). It is known that there are extensive to and 
fro connections between these sensory cortices and the motor cortices (10).We 
postulated that repeated stimulation of the sensory cortices by the vibration therapy 
would strengthen its projections to the motor cortices and thus enhance the central 
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motor output to ultimately increase muscle power. Further, it is established that 40% 
of the descending motor pathways originating from the cortex (corticospinal tracts) is 
formed by the axons of cortical neurons of sensory cortices (Primary and association 
sensory areas (11). Thus sensory cortex stimulation by local area vibration therapy 
may serve to enhance the motor cortical output to the spinal cord. The motor cortices 
which includes the primary motor cortex (Brodmann’s area 4) and the Supplementary 
and Pre-motor cortices (Brodmann’s area 6) plan and program the motor events and 
initiates the skeletal muscle contraction by sending command signals via the 
descending motor pathways to the lower motor neurons supplying the skeletal muscles 
(10,11). Moreover, the normal development of motor functions seen in the normal 
growing child is restricted in the CP child. A contributing factor for this could be the 
reduced sensory feedback the child gets, as the interactions of the CP child with the 
surrounding environment is limited, when compared to the normal child. The CP child 
is not motivated to take part in various activities and to explore the world as much as 
the normal child, due to various degrees of cognitive impairment in addition to motor 
impairment. Thus the normal sensory feedback from tactile and proprioceptive 
receptors, which would aid the development of motor function, is often critically 
reduced in the CP child. The cortex mainly functions through maps. The cortical 
sensory mapping shows that the Palm has got greater area of sensory representation in 
the S1 (10,11,129). So, if the palm is stimulated, greater area of S1 will be stimulated. 
This can produce increased cortical motor excitability by the short term and long term 
neuroplasticity leading to improved transmission of impulses through corticospinal 
tracts, resulting in improved motor functioning of the hand. This argues for the role of 
sensory stimulation as a mode of therapy to enhance the motor function of hand in CP 
children. Thus the therapeutic potential of motor enhancement through peripheral 
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sensory stimulation warrants further investigations. However, to date, there are no 
studies in CP patients which report modulation of cortical motor excitability solely by 
vibratory palmar stimulation, which is a simple, painless, low cost feasible form of 
therapy in the Indian scenario.  
The present study hypothesizes that vibration stimulation of the palmar region of the 
hands of cerebral palsy patients will stimulate a large segment of their sensory cortex 
which in turn will stimulate their motor cortex representing hand, to induce cortical 
plasticity, which will result in improvement of hand motor function of these patients. 
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AIM: 
Aim of the study was to investigate the effect and the usefulness of local area vibration 
therapy in improving motor hand function in cerebral palsy children. 
OBJECTIVES:  
Towards this, the study was designed as a randomized controlled trial where local 
vibration therapy was given only to the intervention group and standard conventional 
therapy was given to both the intervention and control group of cerebral palsy patients. 
Both groups were followed up for a period of 4 weeks during period the intervention 
was given.  
The objectives were: 
a) To compare the change in hand function, assessed by the Box and Block test, 
in the group receiving local vibration therapy in addition to conventional therapy, with 
the group receiving conventional therapy alone. 
b) To compare the change in hand function, assessed by the Box and Block test, 
in each group individually before and after therapy. 
c) To compare the change in the Activities of Daily Living (ADL) measured by 
Modified Barthel Index, in the group receiving local vibration therapy in addition to 
conventional therapy, with the group receiving conventional therapy alone. 
d) To compare the change in the Activities of Daily Living (ADL) measured by 
Modified Barthel Index, in each group individually before and after therapy. 
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MATERIALS AND METHODS:  
To investigate whether sensory stimulation of the hands would produce motor 
improvement in hand function in cerebral palsy patients, a single blinded randomized 
controlled trial was designed. The sensory stimulation was given by applying local 
vibration therapy to the hands. The trial was to study whether local vibration therapy 
had an effect over and above routine standardised therapy, on the motor hand function 
of cerebral palsy children. 
The study was approved by the Institutional Review Board and Ethics Committee. 
TYPE OF STUDY:  
Randomized Controlled Trial, Single blinded. 
The study is registered under Clinical Trial Registry – India (Registry number 
CTRI/2013/05/003700) 
SUBJECTS:  
Cerebral Palsy children who were admitted for therapy in the department of Physical 
medicine and Rehabilitation of the Institute have been recruited. The diagnosis of 
cerebral palsy was made by history, clinical examination of the child and relevant 
investigations as per the protocol of the hospital. The patients who were diagnosed as 
cerebral palsy only had been recruited for the study. 
Cerebral palsy patients with Hemiplegia or Diplegia or Triplegia or Quadriplegia were 
recruited in the study. All the patients were in the age group between 6 – 15 years and 
of either gender.  
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Patients with associated sensory impairment were excluded, as intact sensory 
pathways are crucial to the study to ensure that the sensory impulses reach the cortex. 
Similarly those CP patients who were unable to follow simple 2 step commands were 
not recruited as then, these children would not be able to perform the Box and Block 
test. CP patients with bleeding disorders were also excluded from the study, 
considering the possibility of the vibratory stimuli precipitating bleeding episodes in 
these individuals. So also, those CP children with infective, inflammatory or other 
painful lesions of the hands were excluded. 
PRIMARY OUTCOME: Hand dexterity as assessed using the Box and Block test 
administered immediately before and after the trial. 
SECONDARY OUTCOME: The ability to perform the Activities of Daily Living as 
measured by the Modified Barthel Index computed pre and post intervention. 
SAMPLE SIZE: 
Sample size had been calculated based on the following principle and method: 
The primary outcome of our study was the Box and Block test which measures hand 
dexterity.  Investigators have studied the Box and Block test in 6-19 year old normal 
children to establish normative data in this age group. As per their published findings, 
the normal result of the Box and Block test in 6-19 year olds is 65±6.3 (mean±SD) 
blocks (132) 
A sample size of 25 subjects in each arm of the study was calculated using these 
published results.  
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ASSESSMENT OF PATIENTS (SUBJECTS):  
CP patients admitted in the ward under the PMR department were screened to see if 
they had all the inclusion criteria and to ensure that they did not have any exclusion 
criteria. 
PRE-INTERVENTION ASSESSMENT: 
Pre-test assessment for manual dexterity was done by using a standardized tool called 
the Box and Block test (BBT). The ability of the patients to perform various activities 
of daily living was qualitatively measured by computing the Modified Barthel Index 
(MBI) through a questionnaire for Activity of Daily Living  
1. BOX AND BLOCK TEST: 
INSTRUMENTATION: 
To carry out the test, the Box and Block apparatus and a stop watch are required. 
The Box and Block apparatus consists of three parts, a wooden box, a wooden partition 
and wooden blocks. (Figure 2 and Figure 3) 
Wooden box: A wooden box separated in two equal halves and joined at one edge with 
metal hinge joint. The dimension of the box is 53.7 cm in length, 25.4 cm in breadth 
and 8.5 cm in depth. The two halves of the boxes can be put one upon another so that 
it can be stored like a briefcase when not used. Usually, blocks formed of wooden 
cubes are stored inside the ‘briefcase’. For administering the test, the two halves of the 
boxes are kept open side by side and the separation plate is placed at the junction of 
the two.  
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Wooden partition: A thin wooden partition with dimensions of 25.4 cm x 15.2 cm x 
1cm is placed in between the two equal halves of the box to separate them completely 
when administering the test. The partition can be detached and stored flat inside the 
box when not in use. 
Wooden blocks: These are kept inside the box. Each block is a cube with the 
dimensions of 2.5 cm x 2.5 cm x 2.5 cm. The cubes are of different colours like red, 
green, yellow, blue. A total of 150 cubes are present in one box. 
Stop watch: A standard battery operated stop watch to record time is necessary to carry 
out the test.  
Figure 2: Box and Block Test instrument different parts  
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Figure 3: Box and Block test assembly  
EXPERIMENTAL PROTOCOL 
The handedness of the patients recruited into the study was determined by questioning 
the parents or legal guardians and was confirmed by examining the patients as well.  
Administering the Box and Block test: The place where the test was performed was 
kept free from noise and was secluded from other people and patients to avoid 
distractions for the patient while doing the test.  
The patent is made to sit comfortably on a stool or chair of standard height. Patients 
who can’t sit unsupported, are given support at the back to ensure proper positioning. 
The box and blocks are assembled and the partition plate is kept in the middle of the 
two halves of the box. 
All the blocks are kept on one side of the box. 
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The box is placed on a standard height table, in front of the patient such that the chin 
of the patient is at least 10.5 cm above the mid portion of the partition of the boxes in 
the sitting erect position. 
The Box is initially placed such that the half containing blocks is on the same side as 
the patient’s dominant hand. 
Once the test on dominant hand is over, the box is repositioned such that now the half 
of the box containing blocks, is on the same side as the non-dominant hand. 
The examiner sits on a stool or chair in front of the patient facing the child so that he 
can watch the whole procedure comfortably. 
At the start of the test, all the wooden cubes would be placed on one side of the 
partition. In response to a verbal command the patient has to transfer the cubes from 
one side to the other side as fast as possible, using first his dominant hand, for a period 
of one minute. The test is then repeated after an interval with the patient using his non-
dominant hand to transfer the wooded cubes. The interval time can be variable 
depending on the time taken by individual patient to become ready for the next test. 
The number of cubes transferred over the period of one minute is noted in both cases. 
The patient is allowed to have a trial test for a period of 1 minute.  
The patient is explained about the whole procedure and reassured. The patient was 
instructed to place the hands on either sides of the box, just before the test was started.  
The patient was instructed to start the test as soon as the verbal command to do so was 
given. 
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Initially the patient would transfer the blocks with dominant hand and then with the 
non-dominant hand. An interval was given between tests using dominant and non-
dominant hand. It was given for the patients to get some rest. Once the patient was 
comfortable and confirmed that he or she is ready, the test is carried out for the other 
arm. 
The patient is instructed to transfer the blocks as fast as possible for a fixed period of 
time of one minute. 
During transfer of cube the patient is instructed to move the hand across the wooden 
partition to the opposite side. The block should be released to fall in to the opposite 
side of box. Only one block is to be transported at a time. If more than one block is 
accidentally picked up by the patient, only one would be counted. Or the extra number 
of blocks would be subtracted from the total count at the end of one minute. 
While transferring, if any block is misplaced out of the second box but if the hand had 
crossed the midline before releasing the block, then credit would be given and the 
block would be counted as transferred. 
The examiner monitors the time with the stop watch held in his. The patient should 
continue transferring the blocks for full one minute without any interruption. 
At the end of the test the number of cubes transported correctly was noted. (Figure 4) 
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Precautions to be taken by the patient while performing the Box and Block test: 
Patient should sit erect and comfortably and in a quiet room to avoid any distraction. 
The patient should start transferring blocks from one side to the other as soon as the 
oral command to ‘START’ is given. 
The patient should continue transferring the blocks for one full minute till the STOP 
command is given. 
The transferring should be done as fast as possible without any interruption or 
distraction. 
Only one block must be transferred at a time and the block must be released only when 
the hand crosses above the partition to the other side. 
The patient is advised not to pick up more than one block at a time. However, if more 
than one block is picked up by chance, the patient is advised not to waste time trying 
to keep one back. Instead, the patient is instructed to continue performing the test with 
whatever number of blocks picked up by the hand and as fast as possible.  
Further, the patient is also informed that if accidently, the transferred block falls out 
from the other side onto the table or the floor, to ignore it completely and not to make 
any effort to try to put it back into the box.  
All the above precautions are explained to the patient before administering the test. 
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Figure 4: Box and Block Test in action 
Box and Block test has got some limitations. Since this is a time bound test, any minor 
distraction can reduce the speed of transfer of block and hence can affect the results. 
So in children with less attention span, it may not give accurate results. But doing 
randomization of subjects in our study, we minimized this error. The results also 
depends not only on the motor functions of the patients but on mental status of patient 
as well. All subjects were encouraged to speed up the transfer of blocks during the 
test.  
2. ASSESSMENT OF ACTIVITIES OF DAILY LIVING: 
Activities of daily living are assessed from the Modified Barthel Index. The patient or 
parents of the patient is to answer the questions given in a pre-set, standard 
questionnaire. The patient or the caregiver was asked about the patient’s ability or 
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efficiency in doing activities of daily living such as eating, bathing, brushing teeth. 
The examiner scores the responses based on established guidelines for the answers of 
the questionnaire. 
MODIFIED BARTHEL INDEX: 
The Modified Barthel Index is used to assess the Activities of Daily Living in patients 
with disability. A set of standardized parameters are assessed using a standard 
questionnaire and the responses are scored using the Modified Barthel Index scoring 
system. Dependency needs of individual patient is also  evaluated using the same 
scoring table (127). 
The following activities are assessed and scored as per the Modified Barthel Index 
assessment: 
 Personal hygiene  
 Bathing self 
 Feeding 
 Toilet use 
 Stair climbing 
 Dressing 
 Bowel control ability  
 Bladder control ability 
 Ambulation 
 Wheel chair 
 Chair or bed transfer 
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DEPENDENCY NEEDS ASSESSMENT: 
Dependency needs assessment is done through the scoring table of Modified Barthel 
Index (127) and the following dependency levels are  computed or assigned or 
obtained.  
 Total dependency – if the total score is 0 - 24 
 Severe dependency – if the total score is 25 - 49 
 Moderate dependency – if the total score is 50 – 74  
 Mild dependency – if the total score is 75 – 90  
 Minimal dependency – if the total score is 90 – 99  
ALLOCATION OF PATIENTS INTO GROUPS 
Randomization: Computer generated block randomization code was created using 
the statistical software package SAS.9.2. The so created randomly generated numbers 
were assigned to the intervention group and the control group, as the case may be, 
printed on separate papers and placed in a serially numbered sealed, opaque envelope 
and filed.  
The sealed envelopes are kept with the occupational therapy staff. Randomization is 
done only after the pre-intervention box and block test and MBI scoring have been 
done after the informed consent is obtained. Randomization of the recruited patients 
into the control and intervention group was done by the occupational therapy staff.  
The investigator who recruited the patients and did the pre and post assessment by the 
Box and Block rest and the Modified Barthel Index scoring scoring, was not aware of 
the randomization. 
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Intervention Group and Control Group: 
Thus all the recruited patients were allocated into either the Intervention group or the 
Control group. 
All the recruited patients of both groups were given the standard therapy that all CP 
patients admitted in the ward were given. In addition, the patients in the Intervention 
group received vibration therapy of the palms. 
 
Vibration therapy  
Commercially available hand held portable vibrator has been used in this study to 
administer the vibration therapy. The vibrator is operated electrically with normal AC 
power. It can be regulated at two separate speeds (frequencies) with the help of a 
switch cum regulator, having 0, 1, 2 level of speed. The front adapter of the instrument 
can be connected to fourteen different sets of attachments which actually transmits the 
vibrations to the body surface. In the present study, the attachment with the smooth 
surface was used in all the trials, since smooth surface would ensure least stimulation 
of the touch receptors, while transmitting the vibrations. (Figure 5) 
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    Figure 5: Hand held commercial vibrator 
Detachable adapter 
Regulator 
Cable for power 
Handle 
Smooth surface of adapter attachment 
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Calibration of frequency of vibrator: 
The commercially available vibrator was calibrated using a force transducer and a data 
acquisition system (CMCdaq).  
The force transducer was secured with multiple clamps with a table, fixed to the 
ground to prevent displacement during the procedure. Then the force transducer was 
connected to the CMCdaq and real time recording was obtained by the CMCdaq 
software in the computer. Then vibrator was connected to power and put at the 
regulator 1 frequency. The vibrating instrument is then placed over the force 
transducer. Vibrator was hold lightly over the force transducer to prevent displacement 
of transducer and also to prevent error in the recording due to manual force applied on 
the transducer. The recording of the force transducer was saved in the CMCdaq 
software for analysis. The same procedure was followed when the vibrator was put at 
regulator 2 frequency.  
The analysis of the frequency was done by CMCdaq data analysis software. The 
vibrator caused periodic change of force on the transducer. This periodic change was 
actually at the frequency of the vibrator at which it was vibrating. The frequency of 
the instrument was then calculated by spectral analysis through CMCdaq software. 
The frequency of the low speed of vibration of the instrument was found to be 50 Hz 
(Figure 6) and the frequency of the high speed of vibration was 100 Hz (Figure 7).   
The lower speed of vibration of 50 Hz frequency (low speed, at regulator point 1) of 
the portable vibrator was used to apply vibration therapy in the present study. 
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Figure 6: Spectral analysis of Vibrator frequency through CMCdaq software. 
Recorded using a force transducer. Showing 50 Hz frequency for the low speed 
(Regulator 1). 
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Figure 7: Spectral analysis of Vibrator frequency through CMCdaq software. 
Recorded using a force transducer. Showing 100 Hz frequency for the high 
speed (Regulator 2). 
Protocol for vibration therapy: 
Palmar vibration was given at 50 Hz, with the portable vibrator set at the lower 
frequency and with the smooth surface attachment connected to it. The vibration was 
applied on the palmar surface of both hands of the CP patients such that vibrations of 
30 sec duration was interspersed with rest periods of 30 sec on each palm, alternately. 
Thus when one palm was getting 30 sec rest, the other palm was getting 30 sec of 
vibration.  This was repeated till each palm got a total of 5 minutes of vibration per 
day. Vibration therapy was given in this manner daily, for 5 days a week, for 4 weeks 
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to the CP patients of the intervention group. The vibration therapy was administered 
by the occupational therapist along with other routine therapy and in the same therapy 
room as all the patients. 
Procedure for administering the vibration therapy: 
The patient was made to sit comfortably on a stool or chair. (Figure 8) Those patients 
who could not sit properly, were given suitable support to aid them to sit properly. The 
portable vibrator is then fitted with the detachable adapter. The attachment with the 
smooth surface was fitted to the adapter of the instrument. The vibrator is shown to 
the patient and the patient is allowed to hold it to become familiarised with it and to 
relieve any apprehension. Once the patient was comfortable with the instrument, the 
vibrator was taken back by the occupational therapist. The vibrator was then connected 
to the power source and switched on to the low speed (regulator 1). The patent was 
asked to stretch out one hand opening the fist to expose the palmar surface of hand. 
The dorsum of hand was supported either by the hand of the therapist or was kept on 
the soft pillow. With the vibrator vibrating, the adapter was then placed on the patient’s 
palm. At the onset of touching the palm with the vibrator, the stop watch was 
simultaneously switched on to time the duration of vibration therapy. The patient is 
encouraged to close the fist over the vibrating adapter so as to hold it in the hand. If 
the patient does not close the fist over the vibrator, then the vibrating head was slowly 
moved in a circular manner all over the palm including the fingers. This was continued 
for 30 seconds. After 30 seconds the vibrator is placed on the other palm of the patient, 
following the same procedure. In this way, each of palm is given 30 seconds of 
vibration and 30 seconds of rest alternately till each palm gets a total 5 minutes of 
vibration therapy. 
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The vibrator was then disconnected from the power source. 
This cycle of therapy was given for 5 days a week and for a total of four weeks. 
The Intervention group also received the standard therapy, in addition to the vibration 
therapy. 
 
      
Figure 8: Intervention procedure 
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Control group: 
The patients in the control group were allowed to hold the vibrator in their hand as a 
toy without applying the vibration and without connecting the vibrator to the electrical 
supply. This was done to ensure that there was no bias due to the novelty effect of the 
patients in the intervention group being given therapy with a new instrument. 
In addition to vibration therapy, the intervention group also received the standard 
therapy which was routinely given to all in-patients with CP. 
The control group, however, received standard therapy alone. 
Standard Therapy: 
This consisted of the combined therapy standardised for CP patients and instituted by 
the department of Physical Medicine and Rehabilitation for the treatment of in-patients 
with CP. It consists of a combination of occupational therapy, physiotherapy, speech 
therapy and drug therapy if needed. 
Occupational therapy: It involves 14.5 hours of therapy per week, where the patient is 
trained in the following aspects. 
Training in Balance is given in the sitting, standing and kneeling postures. 
Training is also given to improve the gross motor skills. These are rolling, sitting, 
standing, transferring from one place to another. 
To improve Hand function like reach, grasp, pinch, hand manipulation of objects and 
hand writing, appropriate training is given.  
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ADL training is a form of occupational therapy where the patients are trained for 
activities needed for normal day to day activities. Some of the activities of daily living 
are eating, use of toilet, dressing, maintaining personal hygiene and walking. 
Behaviour and cognitive therapy for patients having behavioural disorders and 
cognitive problems in addition to motor disorders. 
Age appropriate games are played by the children improve all the movements together 
and to improve motor functions. 
Sensory integration therapy is also given to children with cerebral palsy. 
Physiotherapy:  It involves 16.5 hours of therapy per week, where the patient is 
subjected to the following exercise regimes and activities. 
Stretching exercises are carried out to improve spasticity. Stretching reduces the tone 
of the muscles and aids in facilitation of movements of joints. Strengthening exercises 
are done with weight/ resistance ± gravity for better outcome. 
Active exercises for both upper and lower limb are done by the patients as a part of 
physiotherapy. This helps in reducing tone and gaining power of the muscle. 
Trunk control exercise are given as physiotherapy for those who have difficulty in 
attaining an erect posture due to poor power of axial muscles. 
Gait training is also done by parallel bar, walker and crutch. This also video recorded 
and periodically evaluated for improvement. 
Speech therapy: Patients those have difficulty in articulation, speech therapy is applied 
on them for improving speech. 
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Drug therapy: Some patients need administration of drugs, mostly centrally acting 
muscle relaxants to reduce hypertonia and to facilitate movement. 
POST-INTERVENTION ASSESSMENT: 
Post intervention assessment was done on the day of completion of the four weeks of 
therapy or on the day after the therapy ended. The Box and Block test and Activities 
of Daily Living as assessed by Modified Barthel Index were repeated. 
DEFAULTERS: 
One patient in the control arm did not complete the therapy. The patient took voluntary 
discharge from the ward and left in the middle of therapy. Post intervention assessment 
could not be carried out on this patient. Therefore the data of this patient was not 
included in the analysis.  
In 3 patients of the intervention group, the vibration therapy was extended to over 4 
days as the patients had been ill. 
STATISTICAL ANALYSIS: 
Comparison of Pre- and post-intervention Box and block test scores [Median (inter-
quartile ranges)] and Modified Barthel Index scores [Median (inter-quartile ranges)] 
were analysed using Wilcoxon signed rank test. Inter group analysis of Box and Block 
Test score Median [(inter-quartile ranges)] and Modified Barthel Index score [Median 
(inter-quartile ranges)] were calculated using Mann Whitney U test. P value of < 0.05 
was considered as statistically significant. 
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Figure 9: Detailed diagrammatic algorithm of study method 
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RESULTS 
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RESULTS: 
An interim analysis of the ongoing randomised controlled trial was done, the results 
of which are given below. The interim analysis was done after obtaining permission 
from the Institutional review board.  
Subjects: 
A total of 38 CP patients admitted in the department of Physical medicine and 
rehabilitation were screened as of date. Of these, 23 patients were found to be eligible 
for recruitment as per the stated inclusion and exclusion criteria, and were invited to 
participate in the study. All the 23 patients enrolled into the study after giving written 
informed consent. The consent was given either by the patients or the parents. The 
enrolled patients were randomized and allocated into either the control group or the 
treatment group. Of the 23 patients enrolled till now, 20 completed the study, one 
patient discontinued from study and 2 patients are yet to complete the study (Figure 
10). The interim analysis of the data collected from the twenty patients who have 
completed the study is reported here. The interim analysis was done after obtaining 
permission from Institutional review board. Figure 10 gives the flow chart of the study 
to date, according to the Consolidated Standards of Reporting Trials (CONSORT). 
Dropouts: 
Of the 21 patients randomised, one patient discontinued from the study. Thus the 
dropout rate is about 4.8%.  The patient who dropped out was recruited and 
randomized, but requested early discharge for some personal reason and left before 
completion of therapy. 
88 
 
Figure 10: Flow chart of study till date, as per the CONSORT statement  
Demography of participants: 
Of the 20 patients who completed the study, 10 were in the control group and 10 were 
in the intervention group (Table 2). The age of the participants in the control group 
was 10.6±2.99 years (mean±SD) and that of the test group was 10±3.42 years 
(mean±SD). (Table 2; Figure 11) In both groups, there were 6 male (60%) and 4 
female (40%) participants. (Table 2; Figure 12) 
Of the 10 patients in the intervention group 8 had right hand dominance (80%) and 2 
had left hand dominance (20%). In the intervention group 7 had right hand dominance 
(70%) and 3 had left hand dominance (30%). (Table 2; Figure 13) 
In the intervention group there were 4 Spastic diplegic CP (40%), 2 Spastic triplegic 
CP (20%) and 4 Spastic quadriplegic CP (40%). There were also one Ataxic subtype 
(10%) in the intervention group. In the control group there were 1 spastic hemiplegic 
CP (10%), 4 Spastic diplegic CP (20%), 2 Spastic triplegic CP (30%) and 4 Spastic 
Screened
N=38
Enrolled
N=23
Randomized
N=23
Active
N=2
Discontinued 
from study
N=1
Reason: Discharged 
early on request for 
personal reasons
N=1
Completed
N=20
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quadriplegic CP (40%). (Table 2; Figure 14) There were also 2 patients who had 
dystonia in addition (20%) (Table 2; Figure 15). In the intervention group there were 
2 patients who had seizure disorder (20%) and one patient had obesity (10%) as 
comorbidities. In the control group there were 2 seizure disorder (20%), one mental 
retardation (10%), one behavioural problem (10%), and one strabismus (10%) 
patients. (Table 2) 
Table 1: Demographic and clinical data of individual subjects at the time of 
recruitment (N=20) 
  
Sl 
No. 
Age 
(Years) 
Sex(M/F) 
Dominant 
Hand 
(R/L) 
Diagnosis- 
classification 
Co-morbidities 
1 6.5 M R Spastic Triplegic CP 
Obesity, Seizure 
disorder 
2 15 M R 
Spastic Quadriplegic 
CP Seizure disorder 
3 14 M R 
Spastic Quadriplegic 
CP Strabismus 
4 9 M R 
Spastic Quadriplegic 
CP Post encephalitic 
5 7 F R 
Spastic Quadriplegic 
CP 
Ataxia, Seizure 
disorder 
6 10 F R Spastic Diplegic CP Nil 
7 7 M R Spastic Diplegic CP Nil 
8 10 F L 
Spastic Hemiplegic 
CP Dystonia with MR 
9 12 M R Spastic Triplegic CP Dystonia 
10 9 F R Spastic Diplegic CP Nil 
11 8 F L 
Spastic Quadriplegic 
CP Nil 
12 14 F R Spastic Triplegic CP Nil 
13 11 F R Spastic Triplegic CP Nil 
14 12 M R Spastic Triplegic CP Nil  
15 6.5 M R 
Spastic Quadriplegic 
CP Nil 
16 15 F L Spastic Diplegic CP Nil 
17 14 M L Spastic Triplegic CP Nil 
18 7 M R 
Spastic Quadriplegic 
CP 
Seizure disorder, 
Behavioural problem 
19 13 M L Spastic Triplegic CP Nil 
20 6 M R Spastic Diplegic CP Nil 
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Table 2:  Demography and functional classification of study participants in the 
two groups (N=20) 
 
Figure 11: Age of patients in Intervention and Control group 
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Variables Intervention Group  
(N=10)  
Control Group 
(N=10) 
Age(Years) Mean±SD 10±3.42 10.6±2.99 
Sex 
 
 
   
Male - 6 (60%) 
Female - 4 (40%) 
 
 
Male - 6 (60%) 
Female - 4 (40%) 
 
Diagnosis 
Spastic Hemiplegic CP 
Spastic Diplegic CP 
Spastic Triplegic CP 
Spastic Quadriplegic CP 
  
0 (0%) 
4 (30%) 
2 (40%) 
4 (30%) 
  
1 (10%) 
2 (20%) 
3 (30%) 
4 (40%) 
Other Subtypes of CP 
Ataxia 
Dystonia 
 
1 (10%) 
0 (0%) 
 
0 (0%) 
2 (20%) 
Co morbidities 
Seizure disorder 
Mental Retardation 
Behavioural problems  
Strabismus 
Obesity 
 
2 (20%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (10%) 
 
2 (20%) 
1 (10%) 
1 (10%) 
1 (10%) 
0 (0%) 
Dominant Hand  
Right 
Left 
  
8 (80%) 
2 (20%) 
  
7 (70%) 
3 (30%) 
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Figure 12: Gender distribution of Intervention and Control group (M=Male; F= 
Female) 
 
 
 
 
 
Figure 13: Distribution of hand dominance in Intervention and Control group 
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Figure 14: Distribution of different types of CP in Intervention group and 
Control group 
 
 
 
 
 
  
Figure 15: Distribution of other subtypes of Cerebral palsy (CP) in Intervention 
and Control group 
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The severity of the disease of the recruited patients were assessed by the Modified 
Barthel Index score by assessing the activities of daily living. The pre intervention 
assessment showed that 20% and 50% of the patients in the intervention and control 
group respectively had Total dependency. Thirty percent of the patients in the 
intervention group were severely dependent, while 40% in the control group had the 
same level of dependency. There were 40% of patients who were moderately 
dependent, in the intervention group only. Ten percent of patients each in intervention 
and control group had mild dependency. No patient with minimal dependency was 
there in either of the group. (Figure 16) 
 
 
Figure 16: Distribution of baseline dependency needs in Intervention and Control 
Group. 
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Table 3: Pre-intervention and Post-intervention outcome measures of 
Intervention group (N=10) 
Sl 
No. 
BOX AND BLOCK TEST SCORE 
Modified Barthel 
Index  Score 
Dependency needs 
classification 
Dominant Hand 
Non-Dominant 
Hand 
Pre Post Diff  Pre Post Diff   Pre Post Diff Pre Post 
1 10 16 6 8 14 6 31 31 0 Severe Severe 
4 17 24 7 10 9 -1 42 53 11 Severe Moderate 
5 17 25 8 6 16 10 62 70 8 Moderate Moderate 
7 17 24 7 12 20 8 38 38 0 Severe Severe 
10 14 22 8 12 19 7 60 60 0 Moderate Moderate 
12 25 27 2 15 18 3 56 56 0 Moderate Moderate 
14 28 31 3 24 30 6 54 57 3 Moderate Moderate 
15 0 0 0 0 0 0 10 10 0 Total Total 
16 32 44 12 32 39 7 83 91 8 Mild Minimal 
17 20 26 6 3 6 3 4 4 0 Total Total 
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Table 4: Pre-intervention and Post-intervention outcome measures of Control 
group (N=10) 
Sl 
No. 
BOX AND BLOCK TEST SCORE 
Modified Barthel 
Index  Score 
Dependency needs 
classification 
Dominant Hand 
Non-Dominant 
Hand 
Pre Post Diff  Pre Post Diff  Pre Post Diff Pre Post 
2 10 12 2 0 0 0 20 20 0 Total Severe 
3 19 31 12 4 12 8 32 34 2 Severe Total 
6 28 36 8 20 28 8 81 81 0 Mild Severe 
8 15 17 2 12 13 1 20 20 0 Total Mild 
9 25 24 -1 0 1 1 18 18 0 Total Total 
11 9 11 2 7 8 1 22 22 0 Total Total 
13 33 34 1 9 11 2 34 34 0 Severe Total 
19 11 12 1 5 5 0 18 18 0 Total Severe 
20 37 37 0 6 3 -3 39 39 0 Severe Total 
21 26 27 1 25 25 0 40 40 0 Severe Severe 
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Pre intervention Box and Block test score [median (inter-quartile ranges)] of the 
dominant and non-dominant hands in the intervention group were 17 (13, 25.75) and 
11 (5.25, 17.25) respectively. Post intervention, the same scores were 24.5 (20.5, 28) 
and 17 (8.25, 22.5) for dominant and non-dominant hands respectively in the 
intervention group. (Table 5; Figure 17; Figure 18) 
Pre intervention Modified Barthel Index score [median (inter-quartile ranges)] in the 
intervention group was 48 (25.75, 60.5). Post intervention, the same scores was 54.5 
(25.75, 62.5) in the intervention group. (Table 5; Figure 19) 
Comparison of pre- and post-intervention Box and Block test score in the intervention 
group had shown significant difference both in dominant hand (p=0.008) (Table 5; 
Figure 17) and non-dominant hand (p=0.011) (Table 5; Figure 18). But comparison of 
pre- and post-intervention Modified Barthel Index score in the intervention group did 
not show any significant difference (p=0.066) (Table 5; Figure 19) 
Table 5: Comparison of pre-intervention and post-intervention parameters in the 
Intervention group (N=10) 
 
Variable 
 
Pre-intervention 
 
 
Post-intervention 
 
P value 
BBT Score in DH 17 (13, 25.75) 24.5 (20.5, 28) 0.008* 
BBT Score in 
NDH 
11 (5.25, 17.25) 17 (8.25, 22.5) 0.011# 
MBI Score 48 (25.75, 60.5) 54.5 (25.75, 62.5) 0.066 
Values are Median, (IQR); BBT - Box and Block Test; DH - Dominant hand; 
NDH - Non-dominant hand; MBI- Modified Barthel Index. 
 * P < 0.01,  #  P< 0.05  (Wilcoxon signed rank test) 
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Figure 17: Box Plot showing the comparison of Pre and Post Box and Block Test 
(BBT) scores in the Intervention group in DH (Dominant Hand); (N=10) 
* Significantly different from the pre-intervention score, P=0.011, Wilcoxon 
Signed rank Test 
 
 
 
Figure 18: Comparison of Pre and Post Box and Block Test (BBT) scores in the 
Intervention group in NDH (Non-Dominant Hand); (N=10) 
* Significantly different from the pre-intervention score, P=0.008, Wilcoxon 
Signed rank Test 
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Figure 19: Comparison of Pre and Post-intervention Modified Barthel Index 
(MBI) Scores in the Intervention (I) group; (N=10). No significant difference with 
Wilcoxon Signed rank Test 
Pre intervention Box and Block test score [median (inter-quartile ranges)] of the 
dominant and non-dominant hands in the control group were 22 (10.75, 29.25) and 6.5 
(3, 14) respectively. Post intervention, the same scores were 25.5 (12, 34.5) and 9.5 
(2.5, 16) for dominant and non-dominant hands respectively in the control group. 
(Table 6; Figure 20; Figure 21) 
Pre intervention Modified Barthel Index score [median (inter-quartile ranges)] in the 
control group was 27 (19.5, 39.25). Post intervention, the same scores was 28 (19.5, 
39.25) in the control group. (Table 6; Figure 22) 
Comparison of pre- and post-intervention Box and Block test score in the control 
group had shown significant difference in the dominant hand (p=0.016) (Table 6; Fig 
20) but there were no significance in the non-dominant hand (p=0.125) (Table 6; 
Figure 21). Comparison of pre- and post-intervention Modified Barthel Index score in 
the control group did not show any significant difference (p=0.317) (Table 6; Figure 
22) 
99 
 
Table 6: Comparison of pre-intervention and post-intervention parameters in the 
Control group (N=10) 
 
Variable 
 
Pre 
 
 
Post 
 
P value 
BBT Score in DH 22 (10.75, 29.25) 25.5 (12, 34.5) 0.016* 
BBT Score in NDH 6.5 (3, 14) 9.5 (2.5, 16) 0.125 
MBI Score 27 (19.5, 39.25) 28 (19.5, 39.25) 0.317 
Values are Median, (IQR); BBT - Box and Block Test; DH - Dominant hand and 
NDH - Non-dominant hand; MBI- Modified Barthel Index scores.  
 * P < 0.05 (Wilcoxon signed rank test) 
 
 
 
 
 
 
Figure 20: Box Plot showing the comparison of Pre and Post Box and Block Test 
(BBT) scores in the Control group in DH (Dominant Hand); (N=10) 
* Significantly different from the pre-intervention score, p=0.016, Wilcoxon 
Signed rank Test 
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Figure 21: Box Plot showing the comparison of Pre and Post Box and Block Test 
(BBT) scores in the Control group in NDH (Non-Dominant Hand); (N=10). 
No significant difference with Wilcoxon Signed rank Test 
 
 
 
 
 
 
Figure 22: Comparison of Pre and Post-intervention Modified Barthel Index 
(MBI) Scores in the Control (C) group; (N=10). No significant difference with 
Wilcoxon Signed rank Test 
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Inter group comparison of Box and block test score had shown no significant 
difference between intervention and control in both dominant (p=0.062) (Table 7; Fig 
123 and non-dominant hands (p=0.118) (Table 7; Figure 24). Inter group comparison 
of Modified Barthel Index also did not show any significant difference (p=0.091) 
(Table 7; Figure 25).  
The Box and plot graph of the Pre- and Post-intervention difference of Box and Block 
scoring [median (inter-quartile ranges)] showed a definite higher median both in 
dominant hand and non-dominant hand (Figure 23 & Figure 24). 
 
Table 7: Comparison of the change in parameters between Intervention group 
and control group 
Variables 
 
Intervention Group 
(N=10) 
 
Control Group 
(N=10) 
 
P value 
 
Pre-Post difference 
in BBT Score 
(DH)  
6.5 (2.75, 8) 1.5 (0.75, 3.5) 0.062 
Pre-Post difference 
in BBT Score 
(NDH) 
6 (2.25, 7.25) 1 (0.00, 3.5) 0.118 
Pre-Post difference 
in MBI score 
0 (0.00, 8) 0 (0.00, 0.00) 0.091 
Values are Median, (IQR); BBT - Box and Block Test; DH – Dominant Hand; 
NDH - Non-dominant hand; MBI- Modified Barthel Index. No significant 
difference with Mann Whitney U test. 
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Figure 23: Box Plot showing comparison of the change (Pre and Post difference) 
of the Box and Block test (BBT) scores between Intervention (I) and Control (C) 
group in dominant hand (DH). No significant difference with Mann Whitney U 
test 
 
 
Figure 24: Box Plot showing comparison of the change (Pre and Post difference) 
of the Box and Block test (BBT) scores between Intervention (I) and Control (C) 
group in Non-dominant hand (NDH). No significant difference with Mann 
Whitney U test 
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Figure 25: Box Plot showing comparison of the change (Pre and Post difference) 
in Modified Barthel Index (MBI) scores between Intervention and Control group. 
No significant difference with Mann Whitney U test 
 
Post-intervention dependency needs classification based on MBI scoring reveals that 
2 patients (20%) were reclassified to one higher stage. There were, however, no patient 
who could have been reclassified in the control group. (Figure 26) 
 
 
Figure 26: Distribution of patients based on improvement in dependency needs 
based classification in Intervention and control group 
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DISCUSSION: 
There is currently no cure for CP and treatment is mainly supportive to improve quality 
of life by improving functional ability either by improving motor function or by the 
use of assistive devices or techniques (109). Management of cerebral palsy is 
multidisciplinary (110). None of the single therapy alone is sufficient to manage these 
patients. Aim of management is to give a near normal status to patient as far as 
possible. That is why different approaches are sought to improve different parameters 
of the disease condition. Improving motor function is one of the most important aims 
in management since this is essential for becoming self-efficient to carry out work for 
earning a living. To improve quality of life and activities of daily living, ensuring a 
good hand function is one of the essential elements that needs to be addressed.  
Improving motor cortical excitability by exploiting the property of neuroplasticity, 
motor hand function can be improved (3,165,166). Motor cortical excitability can be 
modulated by modulating the sensory cortex since there are multiple to and fro 
connections between them. Sensory stimulation has been shown to modulate the motor 
cortical excitability (155,165,166,169).  
With this background, the present study was done administering local vibration 
therapy, a form of sensory stimulation, to both palms of CP children and the 
improvement in motor hand function was studied. The study was designed as a single-
blinded randomized controlled trial where local vibration therapy was given only to 
the intervention group and standard conventional therapy was given to both the 
intervention and control group of cerebral palsy patients. Both groups were followed 
up for a period of 4 weeks, during which period the intervention was given.  
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The target sample size was 50 with 25 patients in each arm. The study is ongoing with 
active recruitment of patients. With the approval of the Institutional review board, an 
interim analysis of the study was done, to see the effectiveness of vibration therapy in 
patients in the intervention group. At the time of interim analysis, a total of 38 patients 
were screened, 23 patients were recruited into the study and 20 patients had completed 
the study. Details of trial at the time of interim analysis are given in Figure 10. 
It was found that of the 20 CP patients who completed the study, 10 had been allocated 
to the Control group and 10 to the Intervention group. The primary outcome of the 
study was dexterity of the hand as measured by the Box and Block test. The secondary 
outcome was Activities of Daily Living as assessed by the Modified Barthel Index 
score. Both these were measured before and after 4 weeks of the study. 
The findings of the interim analysis showed no statistically significant difference in 
the quantum of change of the primary or secondary outcomes between the intervention 
and control groups. Thus, the change in the Box and Block test score after intervention 
was not statistically different between the intervention and control group [Intervention 
group, Dominant hand 6.5 (2.75, 8); Control group, Dominant hand = 1.5 (0.75, 3.5), 
median (IQR); P = 0.062 and Intervention group, Non-dominant hand 6 (2.25, 7.25); 
Control group, Non-dominant hand = 1 (0.00, 3.5), median (IQR); P = 0.118] (Table 
7; Figure 23; Figure 24). Similarly, the change in the ADL as gauged by the Modified 
Barthel Index score was not statistically significant across the 2 groups [Intervention 
group = 0 (0.00, 8); Control group = 0 (0.00, 0.00), median (IQR); P = 0.091]. (Table 
7; Figure 25) 
However, intra-group analysis revealed statistically significant improvement in the 
Box and Block test score of both the dominant and non-dominant hands of the 
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intervention group, when comparing the post-intervention test score with the pre-
intervention test score [Dominant hand pre-intervention score = 17 (13, 25.75), post-
intervention score = 24.5 (20.5, 28), median (IQR), P = 0.008; Non-dominant hand 
pre-intervention score = 11 (5.25, 17.25), post-intervention score = 17 (8.25, 22.5), 
median (IQR), P = 0.011] (Table 5; Figure 17; Figure 18). Conversely,  in the Control 
group, intra-group analysis revealed statistically significant improvement in the Box 
and Block test score of only the dominant hand [Pre-intervention score = 22 (10.75, 
29.25), Post-intervention score = 25.5 (12, 34.5), median (IQR); P = 0.016] (Table 6; 
Figure 20) and not in the non-dominant hand [Pre-intervention score = 6.5 (3, 14), 
Post-intervention score = 9.5 (2.5, 16), median (IQR); P = 0.125]. (Table 6; Figure 
21). 
The findings of the intra-group analysis of the Box and Block test scores point towards 
an effect of the intervention on improving motor function. As motor function of the 
non-dominant hand of the Intervention group improved but that of the Control group 
did not improve, it would be reasonable to postulate that the difference is contributed 
to by the Vibration therapy.  
As both control and intervention groups were receiving conventional standard therapy 
in the form of various physiotherapy, occupational therapy and behavioural therapy, 
both groups are expected to show an improvement in hand function by the end of 4 
weeks of the study period. So the finding of an improvement of hand dexterity of the 
dominant hand in both the groups is not a surprise, but is an expected finding and 
validates the efficacy of the conventional therapy. However, the improvement in the 
hand function of the dominant hand of the Intervention group was not significantly 
more than that of the dominant hand of the Control group. The same finding was 
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revealed when comparing the change in hand dexterity of the non-dominant hand 
between the groups.  
Nonetheless, the finding of within group analysis, showing a significant improvement 
in dexterity of non-dominant hand in Intervention group, but not in the Control group 
is note-worthy. This result of current interim analysis hints that local palmar vibration 
therapy may be effective in improving motor hand function. This points towards the 
effectiveness of vibration therapy in improving motor functions in cerebral palsy 
children. This revealed that the function of the weaker hand (non-dominant) improved 
in those CP patients who received vibration therapy in addition to standard therapy, 
but not in those who received only standard therapy. Bilateral vibration therapy along 
with standard therapy may be a better way of management than standard therapy alone 
in improving motor function of weaker limb. 
 
 
Figure 27: Sensory and motor cortical areas and their connections 
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The effectiveness of vibration therapy may be explained by the extensive to and fro 
connections between the sensory cortices and motor cortices (10). The primary motor 
cortex (M1) receives somatosensory afferents. The somatosensory input is relayed in 
such a fashion that it comes from an area which is homologous to the motor cortex 
(10). Since both the sensory and motor cortex are somatotopically organized, the 
sensory outputs from one area of sensory cortex transmits tactile and proprioceptive 
information which projects to the same functional area of representation of that region 
in the motor cortex (10,11,129). So the somatosensory area for hand representation 
sends tactile, vibration sense and proprioceptive inputs to the motor hand area which 
when excited causes movements of muscles of hands. All the inputs do not directly 
project to the motor cortex from the somatosensory area. Some sensory inputs are 
relayed through the thalamic relay nucleus to the motor cortex (10). The ventral 
posterolateral nucleus of thalamus is also somatotopically mapped like the 
somatosensory and motor cortices. So the relay is also organized somatotopically from 
somatosensory area of hand representation to the area of hand representation in the 
thalamus to the corresponding hand area of primary motor cortex (10). 
The palmar vibration applied locally to both hands of CP patients of the Intervention 
group would have definitely served as a sensory input to the motor cortex of these 
patients. It may be postulated that this sensory input applied for 5 minutes daily, for 5 
days a week, for 4 weeks initiated neuroplasticity in the motor cortex to aid in the 
motor improvement of hand function of the CP patients of the Intervention group. 
However, as both Intervention and Control group were receiving standard therapy, the 
contribution of vibration therapy may be submerged in the effect of the standard 
therapy. Further conclusions can be drawn only after the trial is completed and final 
analysis is done. 
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Nevertheless this interim analysis has given some useful information. From the results 
of the interim analysis it may be confidently stated that vibration therapy did not 
negatively impact the conventional therapy given to CP patients. Further the interim 
analysis gave an opportunity to validate the methods employed in the study against 
previously published reports. 
The Box and Block test was used for assessing motor function in the CP patients of 
the present study. The Box and Block test is a simple, easy to administer, inexpensive 
test to assess manual dexterity in CP patients. Box and Block test results positively 
correlate with the MACS (Manual Ability Classification System) results in cerebral 
palsy patients (136). The Box and Block test has been validated in children in the age 
group of 6 – 19 years (128,132). The mean age of all the patients recruited into the 
study at the time of interim analysis was 10.5 ± 3.23 years (mean±SD). The oldest CP 
patient was 15 years old and the youngest was 6 years old. In the intervention group 
the mean age of the patients was 10 ± 3.423 years and in the control group it was 10.6 
± 2.98 years. There are also reports of studies which have used the Box and Block test 
to accurately assess hand function in CP children (128,136,138) of 6-19 years. The 
age group of patients of present study matched with these studies. The Box and Block 
test scores obtained by the interim analysis ranged from 0 to 44 (17±11.04, mean±SD) 
which is comparable to previous study done on patients of cerebral palsy, aged 
between 6 to 15 years (138). 
Of the patients who completed the study at the time of interim analysis, 60% were 
male and 40% were female patients in both the intervention and control groups. A 
recent study conducted by the Centre for Disease Control and Prevention (CDC) in 
2008, report in addition to other important epidemiological facts about cerebral palsy, 
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that the disease is more common in males than females (17). The gender distribution 
of the recruited CP patients, as observed in the interim analysis of the present study, 
is in line with this report (17). This is an indication that the study population of present 
study is representative of CP patients of the world. 
All the patients in both intervention and control groups had spastic type of paralysis. 
This is in line with other studies which have reported that spastic type CP is more 
common and accounts for 77.4% of the cases (17). The distribution of different types 
of CP in the 2 groups was found to be in the similar range. Associated co-morbidities 
like Seizure disorders were present in both the groups to almost the same extent. 
Twenty percent of the patients in both intervention and the control group had seizure 
disorders.  
The vibration protocol of the present study consisted of the application of local 
bilateral palmar vibration of 50 Hz vibration frequency. Previous studies have shown 
that vibration in the range of 25 to 80 Hz can improve the motor cortical excitability 
or motor function in  subjects (3,139,165). Prior studies have administered vibration 
therapy for various durations ranging from single episode of application daily for 3 
days, once weekly for 12 weeks, to 5 days a week for 6 months (3,125). In the present 
study protocol vibration therapy was applied for 5 days a week for 4 weeks.  
The damage that occurs in the cortices of CP children are not always equal in extent 
on both sides.  The damage to the 2 hemispheres may be asymmetric, such that one is 
more damaged than the other (170,171). Previous studies have shown that the better 
functioning motor cortex of one hemisphere can inhibit the excitability of the opposite 
worse hemisphere, through the phenomenon of inter-hemispheric inhibition 
(139,166,172). The preferential use of the dominant hand, sub served by the better 
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functioning motor cortex, for daily activities, can further increase the motor cortical 
excitability of the hemisphere dominant for motor function (139). The superior motor 
cortex in turn can inhibit the excitability of the  weaker cortex through the 
phenomenon of inter-hemispheric inhibition through transcallosal connections (139).  
It has been reported that  sensory inputs in the form of vibration stimuli, applied to the 
less mobile hand can negate the effect of inter-hemispheric inhibition  and reduce the 
negative impact that the superior cortex has on the weaker hemisphere (139).  The 
results of the current study corroborate this finding. Unilateral transcranial magnetic 
stimulation of the suppressed cerebral motor cortex or the disadvantaged motor cortex 
has been shown to improve the motor function of the contralateral relatively immobile 
limb. On the other hand, transcranial magnetic stimulation of the normal healthy  
motor cortex further attenuated the function of the immobile limb, through inter-
hemispheric inhibition (139,166,172,173).  In the present study, vibration was applied 
on both the palms of the patients. This would have stimulated both the motor cortices 
(154,166). The better functioning motor cortex could have depressed the function of 
the worse side and thereby reduced the motor functioning of the more paretic limb. 
However, this did not happen in the CP patients who received the intervention, rather 
the motor functioning of the weaker hand also improved in them. The bilateral 
improvement of motor hand function in the intervention group may be accounted for 
by the bilateral application of palmar vibration, adopted in the study protocol for the 
intervention. Thus, interim analysis of the study reveals that the protocol used in the 
study for the application of vibration therapy, has overcome the effects of inter-
hemispheric cortical inhibition, and was useful in producing bilateral improvement in 
hand function in the intervention group. 
113 
 
The finding that non-dominant hand function did not improve with Conventional 
therapy alone, raises questions about the efficacy of the standard therapy in 
strengthening the weaker hand. Is it that the techniques of conventional therapy are 
not addressing the needs of the weaker non-dominant hand? The vibration therapy was 
applied equally to both dominant and non-dominant hands of CP patients to produce 
sensory modulation of both motor cortices. This would have mitigated the effects of 
inter-hemispheric inhibition, as improved hand dexterity was observed in both 
dominant and non-dominant hands of the Intervention group. In the Control group, 
there was no improvement of motor hand function of the non-dominant hand. The 
Control group received only standard conventional therapy. It may be argued that the 
different modes of therapy that made up the conventional therapy, failed to alleviate 
the inter-hemispheric inhibition. Noticeably, standard therapy failed to improve 
dexterity of the non-dominant hand. The finding that vibration therapy succeeded in 
improving motor hand function of non-dominant hand while conventional therapy did  
not, implies that the latter may not be addressing the increased sensory input needs of 
the more damaged or the less functioning cortex.  
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Figure 28: Inter-hemispheric inhibition: showing stimulation of right motor cortex 
stimulates the left limbs and inhibition of left motor cortex through inter-hemispheric 
inhibition and inhibition of right limbs. Similar events are mirrored on the opposite 
side if left motor cortex is stimulated (1-Stimulation of right motor cortex; 2- 
stimulation of left limbs; 3- inhibition of left motor cortex through inter-hemispheric 
inhibition; 4- inhibition of right limbs)  
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Comparison of the post and pre intervention difference in the Box and Block test score, 
between the Intervention & Control groups showed no statistically significant 
difference in both dominant (p=0.062) and non-dominant hand (p=0.118) at this 
juncture of interim analysis. However, the comparison is between the intervention 
group and an active control group, and not a passive control group. Only if vibration 
therapy produced an effect over and above that of conventional therapy, would there 
be a significantly more improvement in the Intervention group compared to the 
Control group. From the findings of the interim analysis it appears that vibration 
therapy has not produced such a marked effect to bring out a difference in the 20 CP 
patients who completed the study at the time of interim analysis. Nonetheless, interim 
analysis also reveals that vibration therapy did not produce any negative impact on the 
motor function or treatment of the in-patient CP children who completed the study. 
The interim analysis also brings out indirect evidences that speaks for a favourable 
effect of vibration therapy on the hand motor functions. The Median value of the Post 
and Pre intervention difference of Box and Block Test (BBT) scores showed a higher 
absolute value in the Intervention group for both dominant and non-dominant hands, 
compared to the Control group, which seems promising (Figure 23; Figure 24). 
Post intervention Modified Barthel Index score compared to pre intervention, both in 
the intervention (p=0.066) (Table 5; Figure 19) and control (p=0.091) (Table 6; Figure 
22) groups had not shown any significant difference. However, 4 patients (40%) in the 
intervention group showed an absolute improvement in Modified Barthel Index score 
compared to just one patient (10%) in the control group. Thus more number of patients 
in the Intervention group showed an absolute improvement in the Modified Barthel 
Index score compared to the control group (Figure 23, Figure 24). Thus, descriptive 
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statistics of the primary and secondary outcomes in this interim analysis, favours 
effectiveness of vibration therapy in improving hand motor function in children with 
CP. 
Studies have shown that vibration can modulate the motor cortical excitability (139). 
It can also reduce the negative effect that prolonged immobilization of hand has on the 
contralateral motor cortex, if applied on the affected hand (139). 
 
 
Figure 29: Showing modulation of sensory-motor cortical excitability through 
sensory stimulation in the form of vibration (S1- Sensory cortex; M1- Primary motor 
cortex; ACST- Anterior corticospinal tract; LCST- Lateral corticospinal tract) 
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The findings of the interim analysis of this study, that vibration therapy could be of 
help in improving motor functions in cerebral palsy children is in line with the findings 
of  previous studies that showed that vibration therapy had improved the motor cortical 
excitability (4,5,124,125). 
Interim analysis showed improvement of motor function of dominant hand in both the 
intervention and control group but the motor improvement of non-dominant hand was 
only observed in intervention group but not in the control group. The study showed 
vibration therapy could be beneficial in improving motor function in cerebral palsy 
children. The therapy failed to produce any statistically significant improvement in 
motor hand function over and above the standard therapy. Since both the intervention 
and control groups received standard therapy and intervention group received 
vibration therapy in addition, the potential effect of vibration therapy alone, against a 
group which received no therapy at all could not be assessed. In spite of this, the 
significant improvement of motor function in the non-dominant hand of the 
intervention group, in the absence of motor improvement in the control group, gives a 
definite clue that vibration therapy as a sensory stimulus, has a role in improving motor 
function and in attenuating the effect of inter-hemispheric inhibition in cerebral palsy 
children. 
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LIMITATIONS 
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LIMITATIONS: 
Direct real time assessment of motor cortical excitability by fMRI or PET scan, 
following sensory stimulation, was not done in the study. Transcranial magnetic 
stimulation would also have been a good tool to evaluate real time motor cortical 
excitability, which was also not done in this study. Present study considered clinical 
outcome data as an indirect evidence of cortical neuroplasticity. Hand dexterity and 
Activities of Daily Living were evaluated as outcome measures, which might require 
large changes in cortical excitability to produce significant changes in its values. 
Lastly, the study design applied to this trial did not have an arm with CP children 
receiving only vibration therapy. Such a design would have enabled comparison of the 
effect of vibration therapy versus no therapy at all, on hand motor function.  It would 
have been unethical to design such a study in a hospital setting where CP children 
admitted for therapy were being recruited in to the study. Hence, results of current 
study showed only the effect of vibration therapy over and above the effect of standard 
therapy. 
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CONCLUSION 
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CONCLUSION: 
A single-blinded, randomised controlled trial was designed to evaluate the efficacy of 
sensory stimulation in improving hand dexterity, over and above standard 
conventional therapy, in children with cerebral palsy. Sensory stimulation was applied 
in the form of local bilateral palmar vibration therapy. Interim analysis of the trial was 
done when 20 recruited CP patients had completed the study. The results of this 
analysis, while giving no conclusive proof for a positive effect of the vibration therapy 
over and above standard therapy, gave other evidences indicating a probable 
favourable role of vibration therapy in improving hand motor function in children with 
cerebral palsy. Further, the findings of the interim analysis revealed that the protocol 
followed in the application of vibration therapy in the study, minimised the negative 
effect of inter-hemispheric inhibition. Inter-hemispheric inhibition is the phenomenon 
whereby the better functioning motor cortex depresses the functioning of the weaker 
motor cortex, especially when more sensory stimuli is received by the dominant 
cortex. In the protocol of the current study, vibration was given equally to both hands, 
which seems to have produced beneficial effects not only in terms of negating the 
effects of inter-hemispheric inhibition, but also in producing an improvement in the 
hand dexterity of the non-dominant hand.  Children in the Control group, while 
demonstrating improved hand dexterity of dominant hand did not show any 
improvement in the non-dominant hand. On the other hand, children in the 
intervention group revealed improvement in function of both hands. From this finding 
it may be postulated that bilateral vibration therapy, along with standard therapy may 
be a better way of management than standard therapy alone, in improving motor 
function of the weaker limb. A definite recommendation can be made only after 
completion of the study. 
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FUTURE COURSE 
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FUTURE COURSE: 
Studies may be designed to explore the effect of vibration therapy applied over other 
parts of the body on the motor function of that part of the body. 
Transcranial Magnetic Stimulation studies can be carried out to correlate the degree 
of modulation of motor cortical excitability with the clinical outcomes of motor 
function. 
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SUMMARY:  
Cerebral palsy is one of the most common causes of physical disability of childhood 
(2). It is a static encephalopathy produced by injury to the developing brain in the 
perinatal period. Clinically it is mainly a disease of posture and movement, although 
there are other co-morbidities. CP is topographically classified-into Hemiplegia, 
Diplegia, Triplegia and Quadriplegia (2). To improve the functional ability of these 
patients, motor improvement is crucial. Hence treatment of CP is aimed at improving 
motor functions through a multidisciplinary approach involving physiotherapy, 
occupational therapy, pharmacotherapy and surgery (13). The normal development of 
motor functions seen in the normal growing child is restricted in the CP child. A 
contributing factor for this is the reduced sensory feedback the child gets, as the 
interactions of the CP child with the surrounding environment is limited. 
Vibration is a form of sensory stimulus which has been investigated as a modality of 
therapy in many conditions like CP, Stroke and Parkinsonism (7,125,163). Whole 
Body Vibration has been reported to produce motor improvement in CP patients (3–
5,125), and local site specific vibration has been found to reduce spasticity in CP 
children (9). The exact mechanism by which the beneficial effect of vibration is 
produced is still not elucidated.  
Extensive to and fro connections exist between the sensory and motor areas of the 
brain cortex (10). The motor cortex receives input from the adjacent sensory cortices, 
namely the primary sensory cortex and the sensory association areas of the parietal 
lobe. Further 40% of the Corticospinal tract fibres (Motor descending pathways) 
originate from the somatosensory cortices, and only the rest arise from motor cortices 
(10,11). The presence of the extensive sensory input to the motor cortices and to the 
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motor descending pathways raised the potential of using sensory stimulation of the 
extremities to produce neuroplasticity and to improve motor function. Would regular 
application of painless sensory stimuli to the palms of cerebral palsy patients enhance 
the excitability of the motor cortex and produce reorganization of the sensory and 
motor cortices through the phenomenon of neural plasticity, leading to improved motor 
functions in these patients? Published literature reports studies, where localized 
electrical or vibratory stimulation increased excitability and reorganization of the 
motor cortex (139,156). This suggests that localized site-specific vibration of the hands 
alone may contribute to improved motor function of the hands.  
The present study addressed this question by designing a single-blinded randomised 
controlled trial, where cerebral palsy patients of age group 6 - 15 years were recruited, 
randomised and allocated into control and intervention groups. Standard treatment was 
given to both groups. In addition, vibratory stimuli were applied to both palms of 
intervention group. The extent of improvement of hand function, as assessed by the 
Box and Block Test in the two groups, was compared. Further, the change in Activities 
of daily Living, measured using Modified Barthel Index, was also compared between 
the 2 groups.  
An interim analysis of the trial was done with the approval of the Institutional review 
board.  A total of 38 CP patients admitted in the department of Physical medicine and 
rehabilitation were screened as of date. Of these, 23 patients were found to be eligible 
for recruitment as per the stated inclusion and exclusion criteria, and were invited to 
participate in the study. Of the 23 patients enrolled till now, 20 completed the study, 
one patient discontinued from study and 2 patients are yet to complete the study. The 
intra-group analysis of box and block test score and Modified Barthel Index score were 
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done using Wilcoxon Signed Tank test. The inter-group comparison of BBT score and 
MBI score were done using Mann Whitney U test. The data was expressed in terms of 
[median (inter-quartile ranges)]. P< 0.05 was considered as significant. The intergroup 
analysis of the change in the box and block test score in both the dominant (p=0.062) 
and non-dominant hand (p=0.118) showed no significant difference between Control 
and Intervention groups. The findings of the intra-group analysis of the Box and Block 
test scores point towards an effect of the intervention on improving motor function. 
Motor function of the non-dominant hand of the Intervention group was improved 
(p=0.011), but that of the Control group did not improve (p=0.125). Both inter-group 
(p=0.091) and intra-group [control: p=0.317; Intervention: p=0.066] comparison of 
Modified Barthel Index score did not show any statistically significant difference. 
However, 4 patients (40%) in the intervention group showed an absolute improvement 
in Modified Barthel Index score compared to just one patient (10%) in the control 
group. Thus more number of patients in the Intervention group showed an absolute 
improvement in the Modified Barthel Index score compared to the control group. All 
these findings point towards the effectiveness of vibration therapy in improving motor 
functions in cerebral palsy children. Moreover the findings of the study demonstrate 
that bilateral vibration therapy can overcome the effect of inter-hemispheric inhibition 
to the damaged cortex. Bilateral vibration therapy along with standard therapy may be 
a better way of management than standard therapy alone in improving motor function 
of the weaker limb.  
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ANNEXURE I: 
Patient’s information sheet and informed consent form in ENGLISH: 
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Patient’s information sheet and informed consent form in TAMIL: 
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Patient’s information sheet and informed consent form in HINDI: 
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